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ABSTRACT 
The pharmacokinetic study examined the glucose and insulinemic responses of 
ingesting a novel protein bar using plant fiber (isomalto-oligosaccharides, IMO). The 
purpose of the study was to determine the glycemic index (GI) and glycemic load (GL) 
during a 2 hour oral glucose tolerance test (OGTT). The study was performed in two 
parts. First, participants ingested a 25 g food bar (FB) or matched 25 g dextrose (PLA). 
Later, ten fasted individuals participated the same experiment while ingesting 2 FB’s or 
50 g of PLA. OGTT results revealed the FB had a GI of 34 [CI 23, 46] and a GL of 8.5 
[CI 5.6, 11.6]. Interestingly, the FB elicited a lower glycemic response with a similar 
insulin response compared to the PLA. In response, the Exercise Study examined 
whether consuming this FB or 25 g PLA prior to, during, and following intense exercise 
would affect exercise performance and/or recovery in twelve resistance-trained males. 
Participants performed 11 resistance-exercises followed by sprint conditioning drills for 
time. Participants donated blood samples, performed isokinetic strength tests, and rated 
perceptions of muscle soreness and hypoglycemia prior to, following exercise and after 
48 hours of recovery. Data were analyzed by general linear model repeated measures 
and are reported as mean change from baseline with 95% confidence intervals. Results 
revealed blood glucose was significantly higher 30-min post-ingestion with PLA (PLA 
3.1 [2.0, 4.3], FB 0.8 [0.2, 1.5] mmol/L, p=0.001) while post-exercise ratio of insulin to 
glucose was greater with FB (PLA 0.04 [0.00, 0.08], FB 0.11 [0.07, 0.15], p=0.013, 
η
2
=0.25). Total lifting volume was maintained to a greater degree from Set 1 to Set 3
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with FB than PLA (PLA -198.26 [-320.1, -76.4], FB -81.7 [-203.6, 40.1] kg, p=0.175, 
η
2
=0.08). Perceived muscle soreness was lower with FB (PLA 1.88 [0.60, 3.17]; FB 0.29
[-0.99, 1.57] cm, p=0.083, η
2
=0.13). No significant differences were observed between
treatments in sprint performance, isokinetic strength, markers of catabolism, stress and 
sex hormones, or inflammatory markers. Results indicate that ingestion of this FB can 
positively affect glucose homeostasis, sustain exercise performance, and lessen 
perceptions of muscle soreness after intense training. 
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NOMENCLATURE 
FB Food Bar, Fitjoy
TM
PLA Placebo, Dextrose 
ESNL Exercise and Sport Nutrition Laboratory 
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VM Distal Vastus Medalis 
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MLVL Mid-Lateral Vastus Lateralis 
NAD Nebraska Agility Drill 
FYD Forty-Yard Dash 
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mmHg Millimeters of Mercury 

















BUN Blood Urea Nitrogen 
CRE Creatinine 
BUN:CRE BUN:Creatinine Ratio 
CK Creatine Kinase 
CPK Creatine Phosphokinase 
UA Uric Acid 
LDH Lactate Dehydrogenase 
TEST Testosterone 
CORT Cortisol 
Cort/Test Cortisol/Testosterone Ratio 
IGR Insulin/Glucose Ratio 
kcal Calories 
TNF-α Tumor Necrosis Factor Alpha 
IFN-γ Interferon Gamma 
IL Interleukin 
NO Nitric Oxide 
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WBC White Blood Cell 
LYM Lymphocyte 
MID Mid-Cell Fraction 
GRAN Granulocytes 
RBC Red Blood Cell 
HGB Hemoglobin 
HCT Hematocrit 
MCV Mean Corpuscle Volume 
MCH Mean Corpuscle Hemoglobin 
MCHC Mean Corpuscle Hemoglobin Concentration 
PLT Platelet 
MVP Mean Platelet Volume 
RDW Red Cell Distribution Width 
P Pressure 
T Time 
SR Sarcoplasmic Reticulum 
SS Steady State 
CRP C - Reactive Protein 
MPS Muscle Protein Synthesis 
GPRS Graphic Pain Rating Scale 
BCKDH branched-chain alpha-keto acid dehydrogenase 
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CHAPTER I 
INTRODUCTION AND RATIONALE 
Background 
Nutrient timing in relation to provision carbohydrates and proteins have been 
reported to play a key role, and be of relative importance in relation to a training session, 
energy substrate use, and potential recovery [1]. Nutrient timing involves the purposeful 
ingestion of nutrients prior to, during, and/or following exercise in an effort to favorably 
impact adaptive responses to acute and chronic exercise such as muscle strength and 
power, body composition, substrate utilization, and physical performance [2-4].  Studies 
have shown that endogenous glycogen stores can be maximized following a high 
carbohydrate diet (8-12g of CHO/kg/day [g/kg/day]), as these stores are typically 
depleted during strenuous high volume exercise [1]. Carbohydrates are of maximal 
importance when the training involves one or more glycogen-depleting bouts in a single 
day, for example a high volume resistance workout followed or preceded by a high 
intensity cardiovascular training session. The importance of carbohydrates in 
maintaining blood glucose significantly increases as the exercise time starts to exceed 
two hours, especially training that approaches three hours [5, 6].  Carbohydrate ingestion 
throughout resistance exercise, especially sessions targeting major muscle groups (e.g. 
squats, deadlifts, pullup, bench press) has been shown to promote euglycemia and 
attenuate the breakdown of glycogen stores.  Consumption of carbohydrate by itself, or 
in combination with protein during resistance exercise increases muscle glucose 
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availability, thus contributing to fuel availability necessary for resistance training and/or 
cardiovascular training. 
Protein timing in relation to resistance training in a fasted state seems to provide 
evidence for maximal importance if consumed more than three hours prior, especially 
approaching or exceeding four hours prior to exercise.  Research has indicated that 
meeting the total daily intake of protein through strategically spaced feedings (~every 3-
h during the day) should be paramount to diets in athletic populations [7].  Moreover, 
ingestion of essential amino acids (EAA) in the form of a protein bolus of 20-40g has 
been shown to simulate muscle protein synthesis in skeletal muscle in humans, and has 
been suggested to attenuate the breakdown of muscle proteins during exercise [8].  
Exercise activates the muscle branched-chain α-keto acid dehydrogenase (BCKDH) 
complex, resulting in BCAA catabolism [9].  Therefore, exercise may require more 
BCAAs prior to, during, or post exercise to attenuate muscle damage and promote 
recovery. 
Specific timing of carbohydrate plus protein supplements may be used for acute 
ergogenic effects rather than chronic muscular adaptations. When carbohydrates are 
ingested, insulin is secreted which normally parallels the elevation in blood glucose. 
The subsequent insulin secretion is the body’s response in attempting to keep blood 
glucose in the normal range of 70-110 mg/dL [10, 11].  Insulin plays a large role in 
anabolism inside the muscle cell, but perhaps more importantly, insulin is anti-catabolic 
thereby inhibiting protein breakdown.  If blood glucose levels can be better maintained, 
one might expect to see a more anabolic and/or a more anti-catabolic environment, 
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leading to less stress and inflammation, and faster recovery. Ingesting adequate amounts 
of protein and carbohydrate prior to, during, and/or following intense exercise, could 
enhance recovery and tissue repair, augment muscle protein synthesis, ameliorate muscle 
damage, promote euglycemia, facilitate glycogen re-synthesis, improve performance, 
and improve mood states following high-volume or intense exercise [12, 13]. If rapid 
restoration of glycogen is required, such as a 48 hour recovery workout, combining 
carbohydrates with protein could prove highly advantageous [1]. 
The research surrounding glucose and insulin maintenance prior to and during 
exercise may have applications to reduce pain and inflammation in diseased and healthy 
individuals [14-16]. Recently, nutritional research has shifted a focus to maintaining a 
lower glycemic index (<70 GI) and glycemic load (GL) food strategies, and 
supplements, as they seem to provide a beneficial effect on blood glucose levels during 
activity.  Food bars offer a quick sufficient way to ingest carbohydrates and/or protein, 
however most commercially available food bars (FB) are higher glycemic (>70 GI). 
Carbohydrates and protein may act synergistically with other compounds contained in 
the supplement, to provide an overall exercise recovery benefit, which might not be just 
from pure carbohydrates alone.  Research has shown that food and supplements 
containing adequate carbohydrate sources can enhance performance and offer some 
recovery benefits. However, a paucity of literature exists on nutrient strategies 
concerning carbohydrate plus protein combinations on resistance-exercise and 
cardiovascular training.  
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Food and supplement companies have been working to develop different 
methods to consume carbohydrate in various forms. Carbohydrate foods differ 
considerably in the GI, or their effects on glucose and insulinemic responses. This is due 
in part to different food properties affecting the digestion and absorption of carbohydrate 
[17, 18]. Moreover, different types of carbohydrate with different GI’s have been 
reported to affect intestinal transport and glucose availability. Towards this end, many 
supplements and gels combine different forms of carbohydrate (e.g., sucrose, etc.) to 
strategize nutrient delivery and absorption [19, 20]. Recently, isomalto-oligosaccharides 
(IMOs) have gained attention in the nutritional supplement industry to due it’s low GI & 
GL, and potential ability to maintain euglycemia, theoretically spurring the potential for 
exercise-based research on reducing muscle damage and inflammation in combination 
with protein.  The proposed theory behind this study is that administration of a food bar 
comprised of an adequate amount of carbohydrate (13 g IMO and 4 g sugar) + protein 
(20 g whey) in combination prior to, during, and post-exercise, may attenuate the muscle 
damaging and catabolic effects of acute intense exercise on performance and recovery. 
Statement of the Problem 
Will ingestion of a food bar containing whey protein and isomalto- 
oligosaccharide as the carbohydrate source more favorably affect glucose homeostasis, 
exercise performance, or recovery from intense exercise in comparison to a carbohydrate 
matched placebo? 
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Purpose of the Research 
The purpose of this research was to examine the glycemic insulinemic responses 
to ingesting this food bar; and to then determine if ingesting this food bar prior to, 
during, and following intense exercise would affect performance and/or recovery. 
General Research Overview 
This study was conducted in two phases.  First, a Pharmacokinetic Study was 
performed to assess the effects of ingesting the FB on glucose homeostasis and insulin as 
well as to determine the glycemic index and glycemic load during a 2 hour oral glucose 
tolerance test (OGTT).  The second study (Exercise Study) involved assessing the effects 
of ingesting the FB prior to, during, and following intense exercise on performance and 
recovery. 
The Pharmacokinetic Study was conducted in a randomized, counter-balanced, 
and crossover manner during a 2 hour OGTT. Twenty healthy men and women donated 
fasting blood samples prior to ingesting a food bar (FB) containing 20 g of a whey 
protein blend, 25 g of carbohydrate (13 g IMO, 4 g sugar, 8 g fiber), and 7 g of fat (1.5g 
saturated) or 25 g of dextrose (PLA), and repeated 7 to 10 days later while ingesting the 
alternative treatment. To accurately obtain a GI and GL, 10 fasted individuals later 
participated in the same experiment while ingesting 2 FB’s or 50 g of dextrose. Blood 
samples were taken at 10, 20, 30, 60, 90, and 120 min post-ingestion while subjective 
ratings related to appetite and hypoglycemia were obtained at 0, 60 and 120 min. The 
independent variable was nutrient intake and dependent variables included blood 
glucose, insulin, and subjective ratings related to appetite and hypoglycemic side effects. 
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This Exercise Study examined whether consuming this FB or PLA prior to, 
during, and following intense exercise (3 treatments) would affect exercise performance 
and/or recovery. Twelve resistance-trained males participated in an open label, 
randomized, counterbalanced, cross-over trial, repeated with alternative treatment 7-d 
later. During testing participants donated venous blood samples, arterialized-venous 
finger samples, and performed graded pain rating scale (GPRS) measurements, 
isokinetic leg extension/flexion maximal voluntary contractions (MVCs), Readiness to 
Perform (RTP), and Eating Satisfaction (ES) surveys were performed with respective 
treatments. Participants performed 11 resistance-exercises (3 sets x 10 repetitions at 70% 
of 1RM) followed by agility and sprint conditioning drills for time. After 48 hours of 
recovery, participants returned to the lab for a fasted venous blood sample and to 
perform GPRS, MVCs, and RTP assessments. The primary outcome measure was 
glucose homeostasis.  Secondary outcome measures included assessment of performance 
(i.e., resistance-exercise lifting volume, agility and sprint performance, and isokinetic 
strength) and recovery as determined by assessing ratings of muscle soreness; markers of 
catabolism, stress, and inflammation; and, ratings of readiness to perform. Additionally, 
dietary energy and macronutrient, subjective ratings of appetite, and subjective ratings of 
hypoglycemia were assessed. 
Hypotheses 
The central hypotheses for the Pharmacokinetic Study are: 
Ho1: There will be significant differences in glucose and insulin response during 2 
hour OGTT between the two groups. 
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Ho2: There will be significant differences among treatments in reported side 
effects. 
The central hypotheses for the Exercise Study are: 
Ho1: There will be significant differences in glucose and insulin response during 
exercise between the two groups. 
Ho2: There will be significant differences between groups in conditioning and 
sprint performance capacity following an intense bout of resistance-exercise 
training. 
Ho3: There will be significant differences between groups in recovery from an 
intense training bout as determined by assessing markers of inflammation, 
muscle damage, muscle soreness, and muscle strength. 
Delimitations 
Pharmacokinetic Study 
1. Twenty (10 female) recreationally active and healthy males and females ages 18-
35 were recruited for the 2 hour OGTT with 25 g 
2. Ten (4 female) recreationally active and healthy males and females ages 18-35
were recruited for the 2 hour OGTT with 50 g. 
3. Eligible participants took part in a familiarization session during which time they
were informed of the study protocol, filled out necessary paperwork including 
informed consent, medical history, exercise performance history forms, 
completed a medical screening, and were scheduled for baseline testing. 
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4. Participants refrained from the consumption of alcohol and any type of physical
activity 24-h prior to each testing session. 
5. Participants were advised to maintain their normal workout/training regimen over
the study duration (on permitted days). 
6. Participants fasted for at least 10-h prior to each testing session.
7. Participants completed a 4-d dietary food record prior to baseline testing, and
were asked to maintain a consistent diet and turn in a 4-d food records each week 
they are involved within the study design. 
Exercise Study 
1. Twelve (n = 12) apparently healthy resistance trained men with current
involvement in resistance training consisting of upper and lower body exercises 
for the past year as well as cardiovascular/sprint conditioning for the past 6 
months, ages 18-35, were recruited for the exercise study. 
2. Eligible participants took part in a familiarization session during which time they
were informed of the study protocol, filled out necessary paperwork including 
informed consent, medical history, exercise performance history forms, 
completed a medical screening, and were scheduled for baseline testing. 
3. Eligible participants who took part in a familiarization session also performed a




4. Participants refrained from the consumption of NSAIDs, analgesics and opioids 
throughout the duration of the study protocol, and refrained from alcohol and any 
type of physical activity 24-h prior and 24-h post to each testing session 
5. Participants were advised to maintain their normal workout/training regimen over 
the study duration (on permitted days). 
6.  Participants fasted for at least 10-h prior to each testing session. 
7. Participants completed a 4-d dietary food record prior to baseline testing, and 
were asked to maintain a consistent diet and turn in a 4-d food records each week 
they are involved within the study design. 
Limitations 
1. Participants were individuals from the Texas A&M University community and 
surrounding fitness facilities that responded to recruitment fliers and emails; 
therefore the selection process was not truly random.  
2. Participants were recruited into the study by set minimum study 
inclusion/exclusion criteria to conduct the crossover study design. 
3.  While there may be some variations in testing times and dietary intake, all efforts 
were made to conduct testing sessions at the same approximate time to account 
for diurnal variations.   
4.  All participants were instructed to maintain their normal training program on 
permitted days as defined by the study protocol. However, exercise habits during 
the duration of the study may have changed and therefore changes in 
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performance measures may have been influenced by individual differences in 
training rather than the assigned supplement. 
5. There may be some innate limitations of the laboratory equipment that was used
for data collection and analysis. 
6. All blood samples were handled and processed uniformly across participants and
testing sessions.  However, due to multiple laboratory staff working with study 




1. Participants answered the entrance questionnaires accurately and honestly prior
to being accepted into the study. 
2. The population, which the sample was drawn from, was normally distributed.
3. The variance among the population sample is approximately equal.
4. The sample was randomly assigned to the different supplement groups, however,
participants and researchers were un-blinded to their supplement during testing 
sessions in the study. 
5. Participants followed the overall protocol that was explained to them during the
familiarization session. 
6. Participants refrained from any alcohol and any type of physical activity 24-h
prior to each of the testing sessions. 
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7. All laboratory equipment was calibrated and functioning properly prior to all 
testing sessions.  
8. Participants fasted for 10-h prior to each testing session that involve a fasting 
blood draw and maintained a consistent hydration status across all testing 
sessions within the study protocol. 
Exercise Study 
1.  Participants answered the entrance questionnaires accurately and honestly prior 
to being accepted into the study.  
2.  The population, which the sample was drawn from, was normally distributed.  
3.  The variance among the population sample is approximately equal.  
4.  The sample was randomly assigned to the different supplement groups, however, 
participants and researchers were un-blinded to their supplement during testing 
sessions in the study.  
5. Participants followed the overall protocol that was explained to them during the 
 familiarization session.  
6. Participants refrained from any alcohol and any type of physical activity 24-h 
prior to each of the testing sessions in both studies, however, participants also 
refrained from use of NSAIDs, analgesics, opioids throughout the study design 
for the Exercise Study.  
7. All laboratory equipment was calibrated and functioning properly prior to all 
testing sessions.  
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8.  Participants maintained a consistent dietary intake and exercise regimen (when 
 permitted) throughout the duration of their respective studies.  
9. Participants fasted for 10-h prior to each testing session that involved a fasting 
blood draw and maintained a consistent hydration status across all testing 
sessions within the study protocol. 
10. Participants honestly answered, to the best of their ability, the graphic pain rating 
scale (GPRS) in response to algometer quadriceps muscle soreness measurement 
within each of the testing sessions, and baseline session. 
11. Participants performed at their maximal potential within the primary exercise 





REVIEW OF LITERATURE 
Introduction 
Optimization of training and recovery are paramount for improved performance 
in the recreationally competitive population, and especially amongst athletes.  In order 
for the human body to chronically adapt to meet the desired demands of sport, resistance 
training and/or anaerobic sprinting/conditioning training, individuals should participate 
in specifically designed training regimens which elicit acute physiological responses 
necessary for adaptation over a prolonged period of time.  As a result, the body will 
progress through a condition of muscular damage, breakdown, and an inflammatory 
response, referred to as exercise-induced muscle damage.  These responses are often the 
result of highly demanding or unfamiliar exercise selection, and especially present when 
eccentric exercise is a focal point of the exercise programming.  The 24-48 hours 
following these types of exercises typically are associated with impaired muscle function 
and symptoms of delayed onset muscle soreness (DOMS).  Strength coach professionals 
attempt to finely tune the art of program designing to implement periodization and 
proper rest and recovery to account for the physiological demands and stressors of 
training, and to minimize performance losses.  Higher trained individuals expectably 
have a greater exercise capacity, and a more highly adapted physiological system, to 
handle the increased training demands of intense resistance training, anaerobic 
sprint/sport conditioning, and repetitive training loads during a consistent exercise 
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regimen.  Introduction of unfamiliar exercises, changes in exercise tempo, and changes 
in repetition ranges to training programs typically promote far greater exercise-induced 
muscle damage as a result of elevated intramuscular damage, stress, and catabolism.  It 
is important for athletes and recreational competitors to accelerate recovery between 
exercise bouts, especially in terms of muscle function and reductions of pain, soreness, 
and inflammation.  Nutrient timing in healthy, exercising adults and/or elite athletes may 
play a key role in maintaining blood glucose homeostasis and insulin responsiveness 
during exercise. Further, the maintenance of fuel availability may assist in augmenting 
muscle protein synthesis and restoring glycogen. This could lead to a more advantageous 
exercise-performance, enhanced recovery, and improved mood states and appetite 
perceptions following high-volume intense exercise or sprint conditioning. The 
following reviews background information related to delayed onset muscle soreness 
which is often experienced with resistance-exercise similar to this study protocol. 
Delayed Onset Muscle Soreness (DOMS) 
Acute bouts of intense exercise produce inflammation, muscle damage, and 
muscle soreness. Stress responses characterized by mechanical eccentric damage to the 
muscle and inflammation can almost mimic physiological stress responses associated 
with adverse cardiovascular episodes and illness [10-12, 21-23]. Intense high volumetric 
workouts consisting of using large muscle groups, even in one single session, can 
consequently trigger load-induced responses.  These responses can be characterized by 
structural muscle damage and inflammation which promote the release of intramuscular 
proteins into the systemic circulation.  These markers of muscle damage and breakdown 
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are sometimes associated with cardiovascular dysfunction, surgery, and disease [10-12, 
21-24].  
After prolonged concentric, isometric, and especially eccentric contractions, 
skeletal muscle becomes fatigued.   Although this is relatively short lived, it can 
decrease athletic performance.  Generally, within 1-2 hours most humans have usually 
recovered full function of the particular muscle group used during the exhaustive 
exercise [25].  Workouts involving multiple series of repetitive eccentric muscular 
contractions can lead to the majority of muscular injury which ultimately lead the 
musculature into the repair sequences of degeneration, inflammation, regeneration, and 
fibrosis [6, 23-27].  Almost all resistance-training sessions involve series of eccentric 
contractions as one must lower the bar or load prior to the concentric contraction to 
complete the lift.  The outcome of such eccentric series leads to sarcomeres becoming 
overstretched, progressively from weakest to strongest.  Each time the active muscle is 
contracted and then relaxed myofilaments are overstretched, leading to more filaments 
failing to re-interdigitate.  This typically results in weaker and more disrupted 
sarcomeres laying longitudinally the length of the myofibril.  
Once one or more sarcomeres have become disrupted, the potential to advance to 
disrupt adjacent and transverse myofibrils increases.  Eventually, a point will be reached 
where structural malformations can lead to membrane damage, often accompanied by 
uncontrolled movement of calcium (Ca
2+
) into the SR. This uncontrolled Ca
2+ 
movement
facilitates another step in the damage process.  These sequential events of eccentric 
muscle damage begin with disruption of the sarcomeres and lead to membrane damage 
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and electron coupling interference.  The combination of these stressors can trigger 
proteolysis proteins, such as calcium activated calpains, which are associated with fiber 
breakdown and repair [28]. 
Muscle soreness following exercise is not a direct result of inflammation and 
muscle breakdown, but rather a product of amassed nociceptor and mechanoreceptor 
sensitivity to chemicals and by-products released during muscular degeneration.  The 
inflammation process implicates aggregation of macrophages and monocytes sensitizing 
group III and group IV afferent fibers.  The onset of swelling and soreness is present at 
24 hours after exercise, and depending on the severity, can last up to another 3-4 days. It 
is common after bouts of intense eccentric muscle damage for individuals to experience 
difficulty in performing finely skilled movements.  Consistent experiments have shown 
that both the sense of force and position of muscles in the human subject can be 
disrupted after eccentric muscle damage [6, 27]. 
A vast majority of the population, including athletes, choose to treat pain and 
inflammation symptoms of exercise with non-steroidal anti-inflammatory (NSAIDs), 
such as ibuprofen and naproxen.  NSAIDs attenuate the inflammatory response via 
inhibition of the cyclooxygenase enzymes (COX-1 and COX-2) that regulate 
inflammatory-stimulating prostaglandin production [23, 25].  NSAID use are widely 
advertised for acute and chronic painful conditions, even though use as been attributable 
to gastrointestinal problems [13].  This concern raises the question if the NSAIDs use is 
actually safe and effective in relieving inflammation and perceptions of muscle soreness.  
NSAID research has remained controversial due to inconsistent reports following 
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exercise  [23, 29-33], while research has implicated that inhibition of COX enzymes 
have demonstrated to compromised skeletal muscle protein synthesis and the function of 
satellite cells, thus presenting a dilemma for hypertrophy, anabolism and recovery.  
Other studies have found no NSAID effect of anabolic processes post-exercise in the 
human musculature [34-36]. Due in part to the safety and efficacy controversy in pain 
relief supplemental research, the topic of nutritional interventions on exercise-recovery 
has received considerable attention in recent years. 
DOMS Timeline  
The sensation of pain and stiffness that typically presents itself from 1-5 days 
following intense bouts of exercise, especially after unaccustomed exercise and 
eccentric-activity, can adversely affect athletic performance, both from voluntary 
reduction of effort or inherent loss of ability to create muscular force [37].  DOMS is 
defined and clinically classified as a type I muscle strain, and can vary from minimal 
muscle stiffness which disappears quickly during routines of daily living, or and present 
excruciating debilitating pain, stiffness, and tenderness in the muscle which restricts 
movement [38, 39]. Generally, the tenderness and sensitivity associated with DOMS is 
initially concentrated in the distal aspect of the muscle as a result of high concentrations 
of pain receptors in the myotendinous muscle region, but begins to diffuse progressively 
by 24-48 hours post exercise [40]. Despite common symptoms of DOMS, the primary 
mechanism of debilitating muscle-damaging exercise still remains to be elucidated due 
to the fact that one model cannot explain the complete facets of the DOMS sensation, in 
response several models have been proposed by researchers [26, 37, 41].   
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A largely debunked theory in the early development of DOMS research was the 
lactic acid theory, which was based on the assumption that lactic acid was a toxic 
metabolic waste product of metabolism and influenced perception of pain [37, 39, 42].  
This theory has been largely rejected due to the increased recruitment of type II fibers 
during concentric contractions failed to result in DOMS-type delayed soreness [43]. 
Further, blood lactic acid concentrations appear to return to pre-exercising levels within 
one hour following cessation of exercise. Research has also failed to distinctly identify a 
correlation between lactic acid concentrations and perceived soreness measurements 
[44].  Congruently, it is broadly accepted that lactic acid is the end product of glycolysis, 
and is essential for continuously regenerating NAD+ to support glycolysis, thus 
providing a drastic change from lactic acid’s understanding and role in the human 
structure as beneficial, rather than detrimental [45]. Lactic acid may however increase 
acute perceptions to pain as hydrogens are released leading to a more acidic (pH < 7.4) 
environment following intense exercise, however, as mentioned before this cannot be 
attributed to DOMS pain symptoms experienced 24-48 hours after exercise cessation 
[46]. 
Other theories involve the aspects regarding connective tissue and muscle 
damage, which stem from any type of eccentric muscle action or kinesthetic braking 
force (downhill running) thus producing higher tensile forces than may be experienced 
with solely concentric muscle actions [41, 47]. Due to the all-or-nothing firing action of 
muscle cells, decreased numbers of muscle fibers are recruited during an eccentric 
contraction compared to the concentric component, of an exercise/lift [48]. 
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Consequently, this results in greater muscular tension produced by the current recruited 
fibers on the connective tissue located at the myotendinous junction and the immediate 
associated distal muscle fibers [38, 48].  Connective tissue content and composition 
differ between type I and type II fibers. Type I (slow-twitch) fibers may demonstrate a 
lowered susceptibility to stretch-induced injury as compared to type II (fast-twitch) 
fibers.  Excessive stretching or strain on the structure of connective tissue may lead to 
muscle soreness  [49, 50].  Evidence provided by measurements of urine excretion of 
hydroxyproline and hydroxylysine subsequent to exercise has provided support for this 
theory as their presence is a result of collagen degradation by overuse, or strain damage 
[48, 50].   
The muscle-damaging enzyme efflux theory centers more the on contractile 
components of muscle and disruption of Z-line structures [49]. Because of the large 
amounts of muscular tension produced, the sarcoplasmic reticulum (SR) can be 
significantly damaged, altering its ability to sequester and maintain calcium levels inside 
the cell.  This can lead to an inhibition of mitochondrial regeneration of ATP production 
and large calcium accumulations inside the cell activate proteases, such as calpains, 
which cause degradation of Z-line proteins in the sarcomere and also induce pain 
sensations from nocireceptor sensory nerve endings [37-39, 41].   
The inflammation theory is based on the findings of edema and inflammatory 
cell presence after repetitive eccentric muscle actions [42, 50, 51].  As a result of tissue 
damage, muscle fibers release proteolytic enzymes that initiate degradation of protein 
cell structures, leading to subsequent increases in cell membrane permeability to small 
20 
blood vessels and an influx of protein-rich fluid into the muscle [52, 53].  Once the 
osmotic pressure is altered in the cell from the influx of exudative fluid, pain is sensed 
by activated group IV sensory neurons [54].  Because of the correlation of time course 
for peak edema appearing with peak muscle soreness, and the lack of time course for 
inflammatory cell aggregation, researchers have elected to also address this method as 
the as the “Tissue Fluid Theory” [39].  Whether the development of edema or the 
inflammatory enzyme secretions are the main causes for the response in DOMS 
symptoms, both provide evidence to induce monocyte and macrophage aggregation at 
the site of muscle damage and produce substances that are sensed by the group III and 
group IV sensory nerve endings within a 24-48 hour time frame [37, 39]. 
As a result of the exact mechanisms not being fully elucidated yet by science, 
researchers have gathered a general consensus that a single theory alone cannot account 
the onset of DOMS.  Instead, researchers have proposed that the theories described 
above may present sequence order to account for the DOMS phenomenon [26, 37, 41, 
53]. The proposed sequence of DOMS begins with the assumption that high tensile 
forces, such as seen with eccentric contractions, cause damage to muscle via disruption 
of structural proteins, specifically at the Z-line.  This is followed by strain on the 
connective tissue near the myotendinous junction and accompanying muscle fibers.  
Subsequent damage to the SR leads to an accumulation of calcium that hinders ATP 
resynthesis as mitochondrial calcium homeostasis is disrupted.  Elevated calcium 
concentrations activate proteolytic calcium-dependent enzymes that degrade desmin and 
perhaps titin proteins at the Z-line [38, 39, 41].  In a period of a few hours, inflammation 
 
 21 
has begun as there is an increase in circulating neutrophils. Shortly thereafter, 
intracellular markers of connective tissue damage (e.g CK) diffuse into the cell plasma 
and interstitial space, attracting monocytes that transition into macrophages around 6-12 
hours. Monocytes and macrophages appear to reach peak concentrations near 48-h. 
Macrophages seem to be responsible for the stimulation of pain sensations in the group 
III and group IV nerve endings, as macrophages yield prostaglandin (PGE2) [37, 39].  At 
present, it appears these sequential events lead to the sensation of the DOMS 
phenomenon, and supplementary pain may be increased with mechanical movement of 
muscles as increased muscle pressure augments a stimulus for nocireceptors already 
excited by PGE2  [42, 50, 51]. 
Hormonal Adaptations 
Testosterone & Cortisol 
Strength, power, fatigue, and endurance in athletes can be directly affected by the 
recovering muscle status.  Insufficient recovery is likely to result in decreased 
performance, which can be indicated in blood biomarker muscle assessments.  The 
research suggests that endocrine regulation of muscle repair/adaptions function should 
focus on anabolic/catabolic balance, specifically testosterone and cortisol [55].  
Testosterone and cortisol are well documented, and validated, markers relating to 
fatigue, recovery, protein synthesis, and homeostasis.  Due to the natural variations in 
individual blood concentrations of testosterone and cortisol, it is prudent to monitor 
progressive changes from baseline at different timelines throughout training/testing (i.e., 
fasted, before training, post training, the day after a rest day).  A decrease in testosterone 
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may indicate that training has exceeded an individual’s tolerance and has reduced the 
anabolic potential [56].  Likewise, in opposition, an increase in cortisol my suggest an 
impaired capacity for protein synthesis leading to a reduction in glycogen replenishment, 
and an increase in protein breakdown and red blood cell production [57].  Seeing how 
testosterone and cortisol work antagonistically, we can get a fairly good idea of anabolic 
status for protein synthesis, red blood cell production, glycogen replenishment.  In 
addition, monitoring a testosterone and cortisol ratio (T:C ratio) during a training session 
may provide further evidence to a relative anabolic-catabolic atmosphere in the body, 
especially in male athletes [55, 58].  The T:C ratio is considered more sensitive to 
training stressors, than either measurement alone. A pronounced reduction in the T:C 
ratio (30%)  has been suggested to be an good indicator of inadequate recovery [59, 60].  
Insulin 
Insulin has been shown to be extremely anabolic, as well as anti-catabolic, and 
can significantly affect the overall anabolism/catabolism in the muscle [61, 62].  Serum 
insulin concentrations parallel response to changes in blood glucose, however the 
response is augmented when protein and/or carbohydrates are ingested prior to, during, 
or post workout [61-65].  Without protein/carbohydrate supplementation, insulin 
concentrations have been shown to reduce levels during an acute bout of resistance-
exercise [66].  Insulin appears to only be anabolic if it is in, or above, the normal range 
as a dose response does not appear to exist.  It also appears to be mostly sensitive to 
blood glucose concentrations and dietary intake.  It is therefore suggested that 
supplementation of carbohydrates, amino acids, or combinations of both, to be ingested 
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prior to, during, and/or immediately following a resistance-exercise bout to maximize 
muscle tissue anabolism and/or prevent muscle catabolism [63].  Moreover, 
supplementation prior to, or during, resistance-exercise may be especially promising due 
to taking advantage of the exercise-induced increase in blood flow (hyperemia) and 
amino acid delivery. 
Muscle Enzymes 
Intense exercise bouts may damage muscle tissue resulting in metabolic markers 
to increase concentration in the human blood serum. Serum levels of skeletal muscle 
enzymes or proteins can be useful markers to identify the functional status of the muscle 
tissue and physiological conditions. Creatine kinase, blood urea nitrogen, creatinine, 
lactate dehydrogenase, are among the most useful serum markers of stress, muscle injury 
or catabolism. These various markers can provide researchers with a composite picture 
of the muscle status. It is broadly recommended to use multiple markers to better 
estimate human physiological conditions. 
Creatine Kinase 
After an intense exercise bout, especially following muscle damaging resistance-
exercise, the enzyme creatine kinase (CK) is released from the muscle tissue into the 
blood. It is very typical for athletes to have an elevated level of CK after training, as 
compared to their baseline serum values.  Serum CK has been proposed to be one of the 
best indirect indicators of the training intensity and overtraining [67, 68]. CK levels peak 
approximately 24 hours post-exercise, but may remain in high circulation for up to a 
week [55].  
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 Ironically, there are still complications regarding the use of CK in this manner, 
as there is great interindividual variability in serum CK.  This provides a problem when 
trying to figure out reliable reference values for athletes.  Moreover, certain factors such 
as gender, training level, muscle mass involved can all influence CK levels to a greater 
extent.  Elevated CK levels for multiple days after a workout may suggest incomplete or 
insufficient recovery.   
Blood Urea Nitrogen & Creatinine 
Markers such as blood urea nitrogen (BUN) can demonstrate comprehensive 
protein synthesis/breakdown [69].  Blood urea nitrogen increases with greater protein 
degradation. Creatinine is a compound which is synthesized through the metabolism of 
creatine and excreted in the urine. A high creatinine measurement in healthy adults is 
usually indicative of a very strenuous workout as high rates of ATP and creatine are 
broken down to sustain work. Increases in creatinine reflect greater nucleotide 
degradation and is often used to assess hydration. Creatinine to BUN ratio 
(BUN:creatinine) is a general marker of whole body catabolism. Increases in the 
BUN:creatinine suggest greater whole body protein degradation. These markers in 
combination are useful to determine an athlete’s overall recovery following a muscle 
damaging bout, especially intense resistance-training. 
Lactate Dehydrogenase 
Lactate dehydrogenase (LDH) is an enzyme that catalyzes the reaction of lactate 
to pyruvate. This is a critically important reaction in the cell for ATP synthesis and 
anaerobiosis. Many different cells in the body contain this enzyme which can reflect 
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intensity or long duration exercise. Some key organs highly rich in LDH are the heart, 
kidney, liver, and skeletal muscle. This enzyme is important for glycolysis both in 
anaerobic respiration and aerobic respiration. Short-term intense effort exercise usually 
causes increases in LDH in the human. Research demonstrates that LDH activity can 
increase up to 3-5 hours during heavy muscular activity [70]. The half-life of LDH 
released from skeletal muscle into the blood is usually around 10 hours. 
Markers of Inflammation 
Regular physical activity is associated with mild trauma followed by recovery 
[71]. When sufficient recovery is allowed to occur, usually an adaptation from training 
occurs and performance will increase over time. However, when exercise intensity or 
volume is increased without proper recovery, mild trauma can become more severe 
which is an often time called “overtraining”. Markers of oxidative stress and 
inflammation have been associated with overtraining and lack of proper recovery [72]. 
The literature has demonstrated that overtraining, and lack of recovery, can induce 
significant rises in inflammatory markers. 
The blood provides biomarkers which express pro-inflammatory macrophage 
activity released by macrophages.  These include growth factors and cytokines, which 
are signaling molecules that are very diverse and numerous, and have wide ranges in 
resting levels.  This creates a struggle to properly measure the inflammation in an athlete 
as a direct measure of blood cytokine presence [55].  However, a good measurement 
used to assess inflammation in an individual is to monitor the increases in cytokines 
from baseline.  
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Interleukins (IL) are a group of naturally occurring proteins which assist in 
signaling between cells. Interleukins are especially important in stimulating growth, 
differentiation, and immune responses such as inflammation. Notable classic pro-
inflammatory cytokines include IL-1ß, TNF-α, IL-6, and IL-8 [55].  TNF-α (tumor 
necrosis factor alpha) is involved in systemic inflammation and is responsible for a wide 
array of signaling events within the cell leading to necrosis or apoptosis. Other common 
cytokines include IL-4, IL-13 and IFN-γ to be measured in this study.  IFN-γ is a is a 
major pro-inflammatory cytokine and a member of the interferons. 
It has been well documented that intense and strenuous exercise produces an 
inflammatory response of cytokines. Some researchers suggest that this response is 
induced from the mobilization and augmentation of neutrophils and monocytes. In 
response, cytokines are released into the circulation to mediate this phenomenon. Among 
these cytokines, TNF-α and IL-1 have traditionally been thought of to be the main 
inducer of the acute phase of inflammation. [73]. The majority of research on these two 
cytokines have revealed that a circulating concentration post exercise is either 
unchanged, or exhibits small delayed increments. Plasma IFN-γ do not appear to alter as 
significantly as IL-6 with exercise. IL-6 appears to greatly increase following exercise, 
and may be influenced by cytokine inhibitors such as cortisol. Exercise studies have 
commonly observed significant increases in TNF-α, IL-1, and IL-6  [74].  
It has recently been demonstrated that endurance exercise augments the release 
of IL-8. Moreover, it has recently been shown that IL-4 concentrations were 
significantly heightened 2 hours after exercise. Although the exact time course is not 
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well understood concerning the appearance of cytokines in the blood, it is conceivable 
that limiting certain aspects of inflammation through nutrition or supplementation might 
present new treatment strategies related to recovery [75]. 
As stated, there is no universally agreed upon threshold for which cytokines 
above is considered elevated. Therefore, it is recommended to use repeated testing at 
multiple time points on healthy athletes/individuals; with baseline measurements, and at 
precise points during or after training or recovery periods [63, 76]. The following 
reviews background information related to nutrient timing strategies which might 
enhance performance and/or recovery. 
Nutrient Timing 
Consumers often ingest carbohydrate and protein energy bars in between meals 
as snacks or prior to exercise in order to increase amino acid availability and/or maintain 
blood glucose during exercise [77-80]. However, many energy bars or drinks have a 
relatively high glycemic index (GI) and therefore may not be not suitable for individuals 
who are glucose intolerant and/or diabetic [79, 81]. Additionally, while it is 
recommended that athletes ingest carbohydrate and protein prior to exercise [77, 80], 
ingesting foods, gels, and/or beverages that have high GI’s may promote hypoglycemia 
during exercise and thereby hasten fatigue [77, 79, 80, 82, 83]. It appears that adding 
different types of carbohydrate with low to high GI’s to whey protein has differential 
effects on glucose and insulin responses following intense resistance-exercise [82]. 
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Carbohydrate 
The literature demonstrating the effects of carbohydrate timing on resistance 
training are limited, however there have been multiple studies revealing that resistance 
training significantly decreases muscle glycogen stores [84-87]. These decreases are 
moderate in comparison to intensive endurance exercise, and benefits are not seen with 
consumption of pre-exercise carbohydrates when performing resistance training in 
moderately glycogen depleted circumstances.  Currently, only one study thus far has 
been able to document that carbohydrate ingestion prior to and during resistance exercise 
has led to improved performance outcomes, but these benefits were only noted in the 
second training session performed later in the same day [88].  In opposition, multiple 
studies have been unable to support any improvements in resistance exercise 
performance [2, 89, 90].   The referenced study by Haff and colleagues [2] did however 
seem to see 49% reduction in loss of muscle glycogen following a 40 min resistance 
training workout where a carbohydrate dose (1.0 g/kg) was given pre-workout and every 
10 min (0.5 g/kg) through the duration of training when compared to a placebo beverage.  
Participant’s isokinetic muscle performance did not show any significant change. 
Glycemic Index 
The Glycemic Index (GI) concept first began in the 1980’s as a way to rank 
carbohydrates based on the measured glucose responses to the ingested food compared 
with a reference carbohydrate, like glucose or white bread [91].  The GI of a 
carbohydrate is a measure of the integrated area under the curve (AUC) resulting from 
an ingested food by that of a standard food. The GL is calculated as the product of the 
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amount of available carbohydrate in a food  and the GI value (using glucose as the 
reference food), divided by 100. Foods are often ranked by their GI or ability to alter 
glucose homeostasis. Carbohydrate foods with a higher GI will raise blood glucose more 
so than a moderate GI and a low GI food. The international tables rank foods with a low 
GI as less than 55, moderate GI between 55-70, and a high GI when greater than 70. The 
reference GI value for glucose is 100. The reported GI values for common sugars are 
maltose (105), dextrose (96), xylose (75), trehalose (70), sucrose (58), honey (55), 
lactose (43), IMO (35), fructose (20), and stevia (0). Other common carbohydrate GI 
values commonly ingested around exercise are Pop Tarts (70), Skittles (70), white rice 
(69), Power Bar (58), potato (54), banana (51), brown rice (50), apple (40), milk (40), 
yogurt (36), spaghetti (32), and peanuts (23) [92]. 
Nutritional recommendations and guidelines for general health and optimal 
performance are often based on the information relating to the GI of a carbohydrate food 
source.  Investigations into pre-exercise meal strategies have provided evidence that 
metabolism and substrate utilization can be effected by low and high GI meals  [91].  It 
appears the primary benefit of the low GI carbohydrate is the lowered resulting post-
ingestion hyperglycemia and hyperinsulinemia. Moreover, the combination with the 
reduction in free fatty acid oxidation, which assists in maintaining euglycemia and may 
result in a more sustained carbohydrate availability during the exercise bout.  Although a 
few studies have shown augmented exercise performance, the majority of studies have 
failed to report a metabolic difference between low and high GI’s translating to 
enhanced exercise capacity or performance [91, 93-95].  
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It is recommended that athletes do not ingest high GI carbohydrates prior or 
during exercise. This recommendation is a strategy to avoid the spike in insulin leading 
to hypoglycemia. Exercise can further induce hypoglycemia following a high GI meal 
with exercise-stimulated glucose uptake, resulting in fatigue, discomfort, and nausea. 
A study by Wee and colleagues [96] examined the effects of ingesting high and 
low GI carbohydrates on pre-exercise meals on running capacity. Eight subjects 
participated in a 70%VO2max treadmill run to exhaustion after an overnight fast. Each 
subject received a 67% carbohydrate, 30% protein, and 3% fat meal containing either a 
high or low GI carbohydrate, and repeated the experiment 7 days later with the alternate 
treatment. There was no difference in endurance capacity between the two treatments, 
however the authors reported a 12% lower carbohydrate, and a 118% increase in fat, 
oxidation when the low GI was ingested during the first 80 min of exercise.  
Wu et al [95] performed a randomized crossover study design with 8 male 
recreational runners who ingested a high (77) and low (37) GI isocaloric meal 3 hours 
before running at 70%VO2max until exhaustion following an overnight fast. The authors 
reported a significantly improved running time to exhaustion for the low GI compared to 
the high GI (Low GI 108.8 ± 4 min; High GI 101.4 ± 4 min, p=0.038). The authors also 
observed a higher fat oxidation rate with the low GI group compared to the high GI 
group (p<0.05). 
DeMarco and colleagues performed a study after an overnight fast using 10 
trained cyclists who consumed a low or high GI meal 30 min prior to performing a 2 
hour 70%VO2max until exhaustion. The authors reported significantly lower insulin levels 
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in the low GI group and significantly higher respiratory exchange ratios in the high GI 
group (p<0.05). The low GI group also reported lower subjective ratings of perceived 
exertion and observed a 59% longer time to exhaustion compared to the high GI 
treatment group. The results from this study suggest an enhanced maximal performance 
following a low GI meal 30 min prior to exercise. 
Further research is needed before recommendations or manipulation to 
carbohydrate GI sources in an athlete’s diet can be set.  It appears that the timing, the 
type, and the amount of carbohydrate may need to be individualized to suit the athlete’s 
sport specific needs, gut distress, and preferences. The current literature seems to suggest 
a benefit for low GI foods on resistance-exercise adaptations in diabetic and pre-diabetic 
individuals [97-99], however more research is needed pertaining to the effects of low to 
high GI nutrient strategies on resistance training in healthy adults. If insulin and blood 
glucose can be better manipulated with low GI foods prior to, and during exercise, one 
might have better success offsetting exercise induced catabolism often observed with 
hypoglycemia and lowered insulinemic responses. 
Isomalto-oligosaccharides 
Isomalto-oligosaccharides (IMO) are a prebiotic high fiber, low calorie source of 
carbohydrate that has been used as a functional food and prebiotic sweetener in Asia for 
over 3 decades [100-104].  The glycemic index for IMOs is 34.66 ± 7.65, which 
represents a low GI [100].  IMOs can be found naturally in assorted fermented foods 
including miso, sake, soy sauce, as well as honey [105].  Commercially available IMOs 
are the market leader in the dietary carbohydrate sector of functional foods in Japan. 
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Isomalto-Oligosaccharides are enzymatically produced and typically are obtained 
from starch hydrolysates such as maltose and maltodextrins, from the action of the α-
transglucosidase, or other alternative methods implying the use of α-amylase and an α-
glucosidase combined with a pullulanase [100, 106, 107] and is typically in an α-(1→6) 
linkages.  Classification of IMO structure can be indicated by linkage types (α-1→2, 3, 
4, or 6) and the proportion and position of each type of linkage (only α-(1→6) or 
combined) [108-110].   
Basic animal studies indicate that IMO’s serve as a soluble dietary fiber and can 
stimulate activity of probiotic gut flora, improve gut function, and help manage 
cholesterol in animals fed on a high fat diet [100, 102, 111-113].  Regulation of the gut 
microbial ecology has gained extensive interest in the scientific community, as well as 
among consumers, in the use of probiotics and prebiotics [114-116].  The use of 
prebiotics seem to overcast an advantage to probiotics due to the various nature of being 
cheaper, carrying less risks, resistance to digestive barrier, and is much easier to 
incorporate into the diet [117-119]. 
 Prebiotics are nondigestible dietary components that effectively pass through the 
digestive tract to the colon, while en route can successfully stimulate proliferation, or 
increase the activity, of select populations of bacteria in the human or animal [120, 121].  
IMOs are among the class of nondigestible oligosaccharides that have gained the most 
attention, and have mostly been developed in Asia countries due to its valuable 
properties and favorable applications to the food industry.  IMOs are low-digestibility 
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glucosyl anomalously linked oligosaccharides (ALOs) [122] which are considered as 
prebiotics and anticariogenic (tending to prevent tooth decay) agents [123].   
Recent data published by Delzenne and Williams [124] support the favorable 
evidence in humans that dietary oligosaccharides can influence hormone production, 
lipid and carbohydrate metabolism, and immune responses in situ, especially in the 
intestinal tract as well as outside the gastrointestinal tract.  IMOs have also revealed a 
positive effect on non-competitive inhibitors of α-glucosidase, which aids in delaying the 
digestion of starch and saccharose, thus promoting an application to several diseases 
including obesity, diabetes, gastritis, gastric ulcers, duodenal ulcers, cancer, and viral 
diseases including hepatitis B and C, HIV, and AIDS.   
Diets including 5-20% IMO have demonstrated an ability to lower abdominal fat 
in mammals [125].  These findings suggest a potential application for individuals 
involved in exercise training to maintain blood glucose availability, prevent 
hypoglycemia, minimize exercise induced protein degradation during exercise, and 
stimulate protein synthesis.  Additional research is needed to further evaluate IMOs and 
their role in exercise, as well as the timing of ingestion pertaining to performance. 
Protein and Amino Acids 
It appears leucine, isoleucine, and valine (BCAAs) catabolism in skeletal muscle 
is regulated by the branched-chain alpha-keto acid dehydrogenase (BCKDH) complex, 
which may have a contributing effect to muscle protein synthesis and muscle growth, 
thus aiding in recovery and preventing the DOMS effect.  It has been proposed that 
exercise training activates the muscle BCKDH complex, which may result in an elevated 
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BCAA catabolism.  As a result, exercise may require an elevated supply of BCAAs to 
meet the requirements of the heightened demands.  A study by Shimomura et al. [8] 
reported that oral BCAA supplementation of ~5 g (males 77 ± 3 mg/kg, females 92 ± 2 
mg/kg body weight ) before and after squat exercise (seven sets of 20 repetition squats) 
in 30 male and female participants, can effectively reduce DOMS and muscle fatigue for 
several days after exercise.  Cockburn and colleagues [126] reported that consuming 
milk, or milk-based carbohydrate + protein supplements immediately after unilateral 
eccentric-concentric knee flexions were able to attenuate symptoms of DOMS for 24 and 
48 hours post-exercise.  The reductions in muscle soreness are likely due to the ingestion 
of high-quality protein from the milk, such as whey.  Gilson et al. [127] found that the 5 
g of essential amino acids (EAA) contained in chocolate milk was able to successfully 
reduce DOMS symptoms more so than an isocaloric carbohydrate drink in 13 
intercollegiate soccer players following a period of increased training duration involving 
resistance-training and aerobic/conditioning drills.   
Skeletal muscle glycogen stores are utilized and can be relatively depleted during 
resistance training and/or cardiovascular training.  A single resistance training session 
has the capacity to reduce endogenous muscle glycogen stores from 24-40%, depending 
on the duration and intensity of the exercise bout [128].  If glycogen is depleted and not 
adequately restored, subsequent exercise training may be compromised and delayed 
recovery symptoms may flourish [129].  Currently, there is not a general agreement in 
relative, or total, amounts of protein or carbohydrate, or carbohydrate + protein 
combinations necessary due to the lack in available literature.  Determination in efficacy 
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of nutrient timing methods involving carbohydrate + protein to enhance recovery and 
performance show promise but need to be further elucidated with research.  More 
research is also needed to investigate the effects of nutrient timing using resistance-
trained individuals as these are the athletes who might require additional nutrient 
delivery surrounding exercise. 
The literature suggests that timing in relation to carbohydrates and proteins may 
play a key role, and be of relative importance in relation to a training session, energy 
substrate use, potential recovery and symptoms of DOMS.  Nutrient timing involves the 
purposeful ingestion of nutrients to favorably impact adaptive responses to acute and 
chronic exercise such as muscle strength and power, body composition, substrate 
utilization, and physical performance. The initial work examining the strategies behind 
nutrient timing began in the 1970-80’s, which examined the effects of carbohydrate 
feedings on glycogen bioavailability, exercise performance, and rates of glycogen 
resynthesis [130-132]. 
It is well documented that glycogen stores are limited in the human body with 
about ~80-100 g being stored in the liver and 300-400 g stored in the skeletal muscle 
[133, 134].   It is critically important to build, and resynthesize glycogen stores prior to, 
and after, exercise as glycogen is the preferred fuel source during moderate to high 
intensity endurance (e.g., 65-80% VO2max)  or resistance-training (e.g., 3-4 sets of ~6-
20 repetitions maximum [RM]) type workouts [135].   Research has indicated that 
carbohydrate operates as the primary source of fuel for up to a few hours during 
moderate to intense exercise.  During resistance training, one study demonstrated a 39% 
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reduction in vastus lateralis muscle glycogen by performing six sets of 12-RM leg 
extension [86].  The importance behind this immense glycogen reduction is that exercise 
performance intensity and output largely decreases as muscle glycogen levels decline 
[134].  Rates of tissue breakdown also increase as glycogen levels decrease, leading to 
the creation of guidelines aimed at maximizing maintenance of stored carbohydrates 
relative to the amount of work necessary for performance [136, 137].  
The literature suggests that the most straightforward guideline to maximizing 
endogenous glycogen stores is to ingest an adequate amount of carbohydrates necessary 
for the intensity and volume of the upcoming training.  Current guidelines suggested by 
the ISSN position stand on nutrient timing, recommend daily intakes of 5-12 g/kg/day of 
carbohydrates, with endurance athletes training at moderate to high intensities (≥ 70% 
VO2max) for more than 12 hours per week, on the upper end of the range (8-12 
g/kg/day) [138-140].  The percentage-based recommendations of 60-70% carbohydrates 
of daily intake have recently decayed because of a lack of ability to meet the required 
demands of carbohydrates needed to be prescribed for athletes whose diets consist of 
high amounts of total food intake or diets restricting caloric intake [135].  
It is notable to point out that the majority of recommendations for carbohydrate 
intake are based off endurance athletes, and specifically in male endurance athletes.  A 
paucity of research surrounds the carbohydrate intake with female athletes, furthermore 
studies have shown that trained female athletes do not oxidize fat and carbohydrate at 
the same rates as their male counterparts, and may even deplete glycogen stores to 
different degrees [141-144].  
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There is novel evidence to suggest that higher protein intakes (> 3 g/kg/day) may 
be necessary for resistance-trained individuals, and optimal protein ingestion might not 
be practical by diet alone.  While it is possible to achieve adequate protein needs through 
diet for trained-individuals, supplementation might be prudent as a practical application 
to employ carbohydrate and protein in reference to food tolerance, digestion, and 
promoting optimal performance and recovery.  
Role of Protein in Recovery 
Since the early 1990’s, research has cemented the idea that exercise and 
macronutrient ingestion interact synergistically to provide a far greater net anabolic 
effect than what exercise or food could deliver alone [61, 145, 146].  Without adequate 
protein feedings in close proximity to an exercise bout, the overall muscle protein 
balance will remain negative following an acute bout of resistance-training [147]. 
Protein feedings following an acute resistance bout significantly increases amino 
acid availability, thus significantly increases the rates of muscle protein synthesis (MPS) 
[148].  Further, the muscle’s anabolic responsiveness and sensitivity to whey protein is 
heightened following an acute resistance-exercise bout [149].  A study by Borsheim et 
al. reported a dose-response outcome of net protein balance in response to 3-6 g dose of 
EAA [150].  Moreover, Tipton and colleagues [151] documented that a 9-15 g EAA 
dose taken pre and post-resistance training augmented a higher net protein increase at 3, 
4, and 24 h post exercise.  
The strategic feedings of protein, in various forms, taken pre, during, and post-
workouts have been shown to maximize skeletal muscle recovery and repair and 
38 
optimize strength and cross-sectional area adaptations [77, 152].  Recent investigations 
have shown that protein supplements such as eggs, whey, casein, beef, and whole milk 
can express an identical, or greater, anabolic response to ingestion of free amino acids 
when taking in equal amounts of EAA’s [153-155]. 
Whey protein ingestion in close proximity to resistance-training has been shown 
to augment the phosphorylation of mTOR and its downstream mRNA translational 
proteins (p70s6K and eIF4BP).  These higher activated proteins and signaling cascades 
further suggest that protein feeding in relation to timing may significantly promote 
muscle hypertrophy [153, 156]. Research from Coffey et al. [157] and others [158-160] 
revealed that the timing of protein feedings near ±2 h anaerobic exercise appears to 
promote enhanced activation of molecular signaling pathways regulating myofibrillar 
and mitochondrial protein synthesis, while also augmenting glycogen synthesis. 
Muscle glycogen stores are critically important for exercise-performance and 
anaerobic conditioning fuel availability. Research has illustrated that adding whey 
protein (0.4 g/kg) to a moderate carbohydrate-containing supplement augments the rate 
of glycogen synthesis [146].  As a further matter, the incorporation of protein facilitates 
the repair and recovery of the muscle post-exercise [161].  These findings are thought to 
be related to the insulin signaling pathway, and are further suspected to be related to a 
greater insulin response post-exercise.  Interestingly, whey protein has also demonstrated 
an ability to promote glycogen synthesis in the liver and muscle to a greater insulin-
dependent fashion than casein [162].  These findings may be due to whey’s capacity to 
upregulate glycogen synthase activity.  In conclusion, the addition of whey protein may 
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enhance recovery, augment protein balance, and improve glycogen replenishment. To 
date, even amongst a substantial amount of literature discussing the concept of protein 
timing, only a very limited number of training studies have been able to assess whether 
strategies implementing pre, during, or post-exercise protein feedings provide 
advantages compared to other time points [163]. 
Pre Exercise - Protein 
The majority of literature on protein feeding on resistance training have 
employed some fashion of protein or EAA prior to the start of exercise [135].  Typically 
these studies also administer some form of protein or EAA of an identical dose during 
the exercise period as well.  Towards this end, one study by Tipton et al. [164] examined 
resistance exercise and responses of muscle protein balance with a 20 g dose of whey 
protein taken prior to and immediately post a bout of lower body resistance training.  
The authors reported that MPS rates were similar and that both groups increased 
between pre-exercise, and post-exercise, but was not significantly different from one 
another, suggesting that the response of net protein balance due to timing of intact 
protein administration alone does not respond to the degree of a combination of free 
amino acids and carbohydrates.  
Anderson and colleagues [165] were among the first to conduct a study looking 
at the effects of protein consumption immediately before and after resistance training 
over multiple weeks.  This study compared the effects of 14 weeks of resistance training 
combined with a timed consumption of a 25 g protein blend (16.6 g whey, 2.8 g casein, 
2.8 g egg white, 2.8 g glutamine) vs carbohydrate (maltodextrin) immediately before and 
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after each workout.  Participants experienced the greatest significant increases in Type I 
(18% ± 5%) and type II (26% ± 5%) muscle fibers size, and squat jump height only 
significantly increased, in the treatment group that ingested the protein blend.  Utilizing 
a similar design approach, Hoffman et al. [166] examined the effect of ten weeks of 42 g 
of hydrolyzed collagen protein supplement timing on the strength, power, and body 
composition in resistance-trained collegiate football athletes.  The results indicate that 
the timing of protein intake immediately before or immediately after exercise, or in the 
morning and evening over the course of ten weeks of resistance-training did not provide 
any added benefit between groups.  It should be noted that collagen hydrolysate is not a 
high quality protein source, further, the DEXA  may not have the sensitivity needed to 
detect minute hypertrophic adaptations to skeletal muscle [167].  The study by Anderson 
and colleagues [165] used histochemical approaches to measure muscle hypertrophy, 
and also fed their participants 20% more calories per day (~36.6 kcal/kg/day), which 
may reveal some of the difference in outcomes between the Hoffman study (~30.4 
kcal/kg/day).   
Recently, Schoenfeld and colleagues [168] compared the effects of consuming 25 
g of whey protein isolate immediately pre- versus post-resistance training (3 sets of 8-12 
RM) in 21 resistance-trained men (> 1 year RT experience).  This study was the first to 
directly compare the long-term effects of protein timing administration before and after 
each resistance-training workout.  Schoenfeld and colleagues helped to further evoke 
questions regarding the quantity, composition, and timing of the meal prior to exercise 
which may play a larger role than previously thought, and may influence the extent of 
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training adaptations seen in studies like this.  Another question raised by the authors was 
the amount of training actually involved in these studies might be inadequate compared 
to individuals who would most likely benefit from protein timing in reference to their 
workouts.  Collegiate athletes train on average four hours per day to reach a total 
allowance of 20 hours per week as deemed by NCAA Bylaw 2.14 (20 hour Rule) [169] 
whereas participants in this type of study category may only train 30 hours over the 
entire exercise-training protocol period. 
During Exercise - Protein 
A limited amount of research exists with the ability to examine the effects of 
protein delivery throughout an acute bout of resistance training.  A greater limitation in 
the literature comes from studies designed to specifically compare the impact of protein 
ingestion during exercise being more beneficial than other times of ingestion.  The study 
by Bird et al. [170, 171] (also mentioned later in the carbohydrate + protein section on 
resistance training) saw an increase in post-exercise insulin levels and reductions of 
cortisol and reductions of markers of muscle breakdown (3-methyl-histidine), alluding to 
a potential benefit in recovery.  However, it should be noted that when investigated over 
a 12-week study, the 6 g of EAA supplement resulted in fewer increases to skeletal 
muscle fiber size, than when combined in a carbohydrate + protein supplement [172].  
Post Exercise-Protein 
Post-exercise protein feeding has been deeply examined in attempt to uncover 
any potential advantages to enhance training adaptations or outcomes dealing with 
resistance training.  A large array of acute studies on exercise and protein timing 
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administration has contributed to many theories and mechanistic explanations for why 
post-resistance training administration might be advantageous to athletes [173-177].  
Other studies reveal that adaptations or enhancements might been seen over much longer 
durations, such as weeks to months, especially following initial exposure to resistance 
training in novice populations [178].  
As mentioned in the “Protein Feeding Pre Resistance Training” section, the vast 
majority of literature examining some feature of protein timing in reference to post 
exercise has also offered an identical bolus of protein immediately prior to that 
resistance training bout [165, 166, 179, 180].  Of these mentioned studies, the ingestion 
of protein [165] or carbohydrate + protein [179] immediately prior to or following 
resistance exercise has resulted in beneficial training outcomes and adaptations.  The 
only study to reveal results in opposition was the study performed by Hoffman and 
colleagues [166] where the participants consumed 42 g of hydrolyzed collagen protein 
(not a high quality protein source) and were in a caloric deficit throughout several weeks 
of resistance training in highly-trained collegiate football players. 
A small number of studies have solely inspected the impact of protein 
administration post exercise. Tipton et al. [164] examined if ingestion of whole proteins 
before exercise would have the same impact as previously demonstrated by their work 
with EAA + carbohydrates [181].  This study used an acute model to measure the 
response of MPS when a 20 g bolus of whey protein was ingested both before and 
following lower-body resistance training.  The results indicated that MPS rates were 
increased significantly in both groups (Pre or Post), with no difference between groups. 
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A study performed by Esmarck and colleagues [182] looked at the effects of 
post-exercise protein ingestion in a longitudinal fashion on 13 elderly men (age, 74 ± 1 
year).  The participants consumed an oral liquid dose of carbohydrate (7 g), protein (10 
g), and fat (3 g) either immediately post-exercise (within 30 min) or delayed after each 
exercise bout (within two hour) performed three times per week for 12 weeks.  The 
authors reported that protein ingestion immediately post resistance training led to far 
greater enhancements in muscle strength and muscle cross-sectional area (CSA) than 
when the same dose of nutrients was ingested 2 hours delayed.  The authors also 
reported that no measureable increase in muscle CSA followed completion of the study 
in the delayed two hour group, which led reviewers to somewhat question the outcomes 
from this particular study [183, 184].   
Candow and colleagues [185] produced a study which demonstrates that 10 g of 
protein was most likely an inadequate dose of protein for this age group performed in the 
aforementioned study.  Schoenfeld and colleagues [168] performed a study investigating 
muscle strength, hypertrophy, and body composition changes in response to an equal 
dose of protein (25 g of whey), which offers support that whey protein consumed before 
or after resistance workouts can promote beneficial strength and hypertrophy 
improvements, however the timing of such protein ingestion strategies do not necessarily 
take precedence over other feeding strategies.   
Other reviews by Aragon and Schoenfeld [186] and Schoenfeld and colleagues 
[187] looked to extensively examine the efficacy of protein timing following post 
resistance training ingestion.  The aforementioned authors suggest that protein intake 
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timing may have little effect if adequate or recommended protein levels have already 
been consumed.  The literature does however demonstrate that skeletal muscle remains 
sensitive to protein nutrient delivery for at least 24 hours post resistance training, 
alluding to the possibility that protein timing, quantity, or bolus may have an impact to 
some level in training adaptations.  Further, MacNaughton et al. [188] investigated the 
influence of 20 or 40 g of whey protein following a bout of whole-body resistance 
exercise in resistance-trained males.  The authors reported that the acute bolus of 40 g of 
whey protein resulted in greater increases in MPS when targeting full body major muscle 
groups.  This data suggests more of a protein dose effect; however these findings do 
suggest a significance in a timing interaction despite the ability of the higher dose to 
seemingly elicit more of a beneficial response. In conclusion, the amount of studies that 
have truly investigated the timing response is still rather small.  In addition, a very small 
number of studies have examined the nutrient timing used by highly-trained athletes in 
reference to benefits including skeletal muscle outcomes, performance, or recovery 
[135]. 
Carbohydrate and Protein 
If rapid restoration of glycogen is necessary for a subsequent exercise bout, 
aggressive carbohydrate refeeding (1.2 g/kg/h) or combining carbohydrates (0.8 g/kg/h) 
with protein (0.2-0.4 g/kg/h) might be considered.  Notably, extended (> 60 min) bouts 
of high intensity (> 70% VO2max) challenges bioavailability of fuel supply, hence a 
carbohydrate should be ingested at a rate of ~30-60 g of carbohydrate/hour.  If 
carbohydrates are not available, or delivery of such is inadequate, the ingestion of 
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protein may aid to attenuate muscle damage, maintain euglycemia, and enhance 
glycogen restoration [135].  Further, pre-, during, and post exercise strategies involving 
carbohydrate in combination with protein may work as an effective strategy to increase 
strength and promote recovery, however, the timing and quantity of the meal may impact 
the subsequent exercise. More research is needed to fully elucidate the strategies. 
 Pre Exercise - Carbohydrate and Protein 
 A small group of studies are available examining carbohydrate plus protein 
administration prior to resistance training.  Kraemer et al. [189] investigated a 
combination of carbohydrate, protein, and fat or a matched placebo for seven days prior 
to two consecutive days of heavy resistance training.  The supplement was taken 30 min 
prior to the exercise bout on both training days, and led to improved vertical jump 
power, repetitions at 80% RM, and potentiated endocrine signaling, such as testosterone, 
following heavy resistance exercise.   
Comparable outcomes were reported by Baty et al. [190] where they recruited 34 
males to perform an acute bout of resistance training (3 set of  8 repetitions at 90% RM) 
while consuming a carbohydrate (6.2 % CHO) or a carbohydrate with protein (6.2% 
CHO + 1.5% PRO) 30 min prior to exercise, as well as during, and post-exercise.  There 
were no relative differences between groups on exercise performance, however the 
carbohydrate with protein treatment led to significantly greater insulin and lower cortisol 




In contrast, White and colleagues [191] completed a study examining the specific 
timing of carbohydrate plus protein consumption had any impact on markers of muscle 
damage and isokinetic maximal voluntary force production.  Twenty-seven untrained 
men were given a non-caloric sweetener or a carbohydrate (75 g) + protein (23 g) 
combination 15 min prior and 15 post-exercise during a bout of damaging resistance 
training.  The results indicated that the nutritional strategies and the timing had no 
difference in effect on force production or markers of muscle damage. 
During Exercise - Carbohydrate and Protein 
 As of current literature, the examination of carbohydrate and protein or amino 
acid combination on acute effects during resistance training has been studied, although 
no studies have truly focused on the question of carbohydrate plus protein nutrient 
timing on such [170-172, 192, 193].  With that being said, carbohydrate with protein 
combinations during resistance training have been proposed to improve skeletal muscle 
development due to an augmented insulin response, as insulin has anti-catabolic effects 
on skeletal muscle growth [194, 195].      
Bird and colleagues [170-172, 193] completed a series of studies examining the 
effects of ingesting a carbohydrate or carbohydrate with EAA on measures of acute 
performance, as well as markers of muscle damage.  One of the series of studies by Bird 
et al. [170] recruited 32 participants to consume a 6% carbohydrate solution, a 6% 
carbohydrate plus 6 g EAA solution or a placebo beverage routinely during a 60 min 
resistance training bout.  After examination, the carbohydrate + EAA combination 
solution led towards a more favorable anabolic environment by stimulating insulin 
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release and lowered muscle protein breakdown markers by 27%, including a suppression 
of exercise-induced cortisol response.   
Another study by Bird et al. [193] utilized a triphasic protocol inside a crossover 
study design where a multinutrient carbohydrate with an amino acid combination or 
similar placebo was given prior to, during and after a bout of resistance exercise to 15 
male strength-trained athletes.  Results indicated that resistance exercise performance 
was significantly improved with the nutrient delivery (as compared to none at all) and 
markers of muscle damage were attenuated (creatine kinase and C-reactive protein).   
A study by Beelen et al. [192] examined the potential to modulate protein 
synthesis during exercise.  The study investigated participants in a fed state and 
administered a carbohydrate combination with hydrolyzed casein protein combination 
bolus (0.15 g/kg body mass) prior to the start of a two hour resistance-training session 
and at 15 min increments throughout the exercise.  As a consequence, the carbohydrate 
and protein combination led to significantly lower protein breakdown rates, stimulated 
an increase in whole body and muscle protein synthesis rates by 49 ± 22% during 
resistance exercise, and achieved a positive net protein balance (16.3 ± 0.4 µm) whereas 
whole body net protein balance was negative in the carbohydrate only group (-4.4 ± 0.3 
µm).   
 Bird and colleagues [172] conducted a study pertaining to the chronic effects of 
examining 6% carbohydrate with 6 g EAA solution administered throughout resistance 
exercise (two bouts/week) over twelve weeks.  Their results indicated urinary 
concentrations of histidine were 26% lower with the carbohydrate plus EAA 
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combination compared to a 52% increase seen in the placebo group.  However, these 
findings may be limited to the amount of EAA consumed as other research has indicated 
that MPS may be maximally stimulated with 12 g of EAA.  Future research in nutrient 
delivery should look to analyze different doses of EAA and/or combining with different 
doses of carbohydrate to determine if performance benefits are further enhanced from 
the protein that is supplied or the amount of carbohydrate combined.  In reference to this, 
Hulmi et al. [196] found no benefit in resistance training adaptations by adding a 
combination of carbohydrate (34.5 g) + whey protein concentrate (37.5 g) compared to 
protein supplement alone in a 12 week resistance-exercise protocol. 
Post Exercise - Carbohydrate and Protein 
A post workout supplement would ideally contain at least 45 g of whey protein to 
increase the insulin concentration in the optimal range of ~15-30 µIU/mL to reduce 
proteolysis [197].  This gives rise to the question of efficacy to added carbohydrate 
supplementation to influence muscle development when sufficient protein is already 
supplied.  In this respect, Staples et al. [198] recruited nine men to perform a single bout 
of four sets of 8-12 repetitions to failure on knee extension followed by consumption of 
protein (25 g whey), carbohydrate (25 g maltodextrin), or a combination of said protein 
with carbohydrate supplements on rates of MPS.  The study reported that the 
carbohydrate plus protein combination failed to produce an added increase in MPS when 
compared to only protein administration.  Further, Rasmussen et al. [199] also reported 
no difference in amino acid net balance after a bolus ingestion of a drink containing 
sucrose (35 g) with EAA (6 g) at one or three hours post resistance training.  It would 
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appear that much more literature is needed under this topic to further provide scientific 
knowledge and practical applications to use these feeding strategies following 
resistance-exercise. 
Recovery Markers 
Small molecules, such as proteins, metabolites, and electrolytes, can serve as key 
biomarkers for athletes and recreationally active individuals in assessing recovery for 
health and/or performance [55]. Current advances in scientific technology advocate that 
using intrinsic data such as biochemical and hematological markers can employ a 
powerful role in identifying stress and recovery in each unique individual. Many 
commercially available kits are used to assess biomarkers of health, performance, and 
recovery, in hopes of reducing overtraining or risk of injury, while attempting to better 
understand recovery and aspects of enhancing it.  With this being said, there are still 
many challenges of biomarker testing; including single biomarkers are not definitive for 
diagnosing broad physiological “recovery”, reference ranges for athletes and recreational 
individuals are not yet specifically defined, as well as interindividual variance in 
absolute values and relative changes in biomarkers. 
Most researchers agree that multiple cytokines should be measured together to 
assess physiological function of inflammation [200]. Data utilizing multiple 
inflammatory cytokines, endocrine markers of dysregulation like testosterone and 
cortisol, and muscle damage markers such as creatine kinase (CK), can assist in 
identifying precise and accurate measurements of an athlete’s health.  Moreover, simply 
relying on a single marker for accurate information is not well received, given the 
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simplistic nature of most human biomarkers [71].  Since athletes may display a greater 
range or variability in their values compared to non-exercising or average individuals, 
absolute or one-time measurements in values of cytokines and biomarkers may not give 
meaningful data and responsiveness.  A more representative value of biomarkers might 
be taken before and after an acute challenging exercise bout.  The absolute resting levels 
of the biomarkers may not change from baseline, although the stress could be atypical.  
In response, the timing of measurement of markers should be assessed over multiple 
time points to really understand the fluctuation of biomarkers of an individual in 
response to an acute bout of exercise and recovery over the course of hours, days, and 
weeks [55].  Testing prior to, and post-exercise will assist in elucidating biomarker 
responses to acute exercise.  This could be very valuable when resting values fail to 
pinpoint any changes. 
Rationale of Study 
Ingestion of nutrients prior to exercise contributes to fuel availability which may 
reduce catabolism during exercise and promote recovery.  It appears the implementation 
of carbohydrate with protein (or EAA) surrounding, or during, both endurance and 
resistance training may be an effective nutrient strategy to positively enhance exercise 
performance, adaptations to training, or favorably enhance recovery. Furthermore, 
favorable performance benefits to training have been reported with carbohydrate and 
protein supplementation in close proximity to exercise bouts, in particular if less than 
adequate amounts of carbohydrate are consumed beforehand.   
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When adequate carbohydrates are consumed, the influence of additional protein 
appears to have little to no enhancing effect on endurance or resistance exercise 
performance and/or recovery of muscle glycogen.  It seems that if total protein priorities 
are met throughout the day and therefor daily protein levels are met, the importance of 
added carbohydrates may be limited.  One area of future studies might be in highly 
trained athletes, where total energy needs might also need to be met because the athletes 
experience large volumes of training and/or have large amounts of lean body mass. 
These athletes may require the addition of a carbohydrate + protein to allow the athlete 
to meet an appropriate energy obligation to impact recovery or muscular adaptations 
before, during, or after exercise. Towards this end, athletes who must combine resistance 
training and endurance type training (or sport-specific training) might warrant additions 
of carbohydrate with protein supplementations in close timing to their sessions to 
optimize recovery periods and decrease muscle breakdown. Other athletes who might 
consider the supplementation of carbohydrate with protein supplements to their diets are 
athletes who must train in the early mornings, and may not have time to consume an 
adequate meal prior to vigorous exercise expenditure.  
It is recommended that athletes consume low to moderate sources of 
carbohydrate and 10-20 g of high quality protein prior to intense and prolonged training 
in order to maintain blood glucose availability, prevent hypoglycemia, minimize 
exercise induced protein degradation during exercise, and stimulate protein synthesis 
following exercise [1, 201]. However most commercially available energy/food bars 
contain large amounts of high glycemic carbohydrate and/or low amounts of quality 
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protein which may not be optimal for athletes to ingest prior to exercise.  Additionally, 
they are typically marketed as in-between meal snacks [202].   
We have been working with Nutrabolt to determine the glycemic index (GI) and 
glycemic load (GL) of an innovative new energy/food bar that contains low-glycemic 
sources of carbohydrate (IMO and plant fiber) and 20 g of high quality whey protein that 
would provide more than 6 g of EAA.  We have found that his energy/food bar has a low 
GI of 34 and GL of 8.5 while promoting a similar insulin response to a high GI 
carbohydrate (dextrose) [203].  Theoretically, this may serve as an optimal pre-exercise 
source of carbohydrate while stimulating an insulin response thereby reducing 
catabolism during or post-exercise.   Current literature suggests there may be a dose 
and/or significance in timing effect, however the amount of literature available is rather 
small, even more so when examining nutrient timing in highly-trained individuals.  
Additionally, there is a paucity of research surrounding the role nutrient timing, 
specifically carbohydrate in combination with protein on both endurance and resistance-
training.  
There is also a need to investigate the effects of ingestion of IMO and exercise 
performance. IMOs could present an advantage on blood glucose and insulin in healthy 
adults.  Isomalto-oligosaccharides are produced from highly available and relatively 
low-cost plant materials through simple enzymatic processes.  They have also proven 
their enhancing effects on metabolism, bifidogenic flora, bowel functions, and the 
immune system.  In this context, IMOs could theoretically serve as a low glycemic food 
option for individuals on a low glycemic diet and/or athletes. 
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This study will determine whether ingesting this innovative energy/food bar that 
displays a IMO carbohydrate and protein combination strategy prior to, during, and post 
exercise will affect performance and/or recovery.   In this study, we are using an exercise 
and recovery protocol that has previously studied the effects of ingesting protein with 
various forms of carbohydrate on resistance-exercise and recovery [204] to examine the 
acute effects of ingesting a commercially available low glycemic carbohydrate / whey 
protein food bar on exercise capacity and recovery from an intense resistance-exercise 
and sprint conditioning training bout.  Successful completion of the study aims could 
influence the scientific knowledge and practical applications of use of these types of 
energy/food bars around exercise. Further, this study will add to the understanding of 
nutrient timing and whether or not it may influence acute intense resistance/conditioning 




GLYCEMIC AND INSULINEMIC RESPONSE TO INGESTION OF A NOVEL 
FOOD BAR CONTAINING WHEY PROTEIN AND ISOMALTO-
OLIGOSACCHARIDES* 
Introduction 
Consumers often ingest carbohydrate and protein energy bars in between meals 
as snacks or prior to exercise in order to increase amino acid availability and/or maintain 
blood glucose during exercise [77-80]. However, many energy bars or drinks have a 
relatively high glycemic index (GI) and therefore may not be not suitable for individuals 
who are glucose intolerant and/or diabetic [79, 81]. Additionally, while it is 
recommended that athletes ingest carbohydrate and protein prior to exercise [77, 80], 
ingesting foods, gels, and/or beverages that have high GI’s may promote hypoglycemia 
during exercise and thereby hasten fatigue [77, 79, 80, 82, 83]. For example, we 
previously reported that ingestion of moderate to low GI carbohydrate gel during 
prolonged cycling maintained blood glucose and insulin levels to a greater degree than a 
higher GI gel [83]. Additionally, that adding different types of carbohydrate with low to 
high GI’s to whey protein had differential effects on glucose and insulin responses 
following intense resistance-exercise [82]. 
*Reprinted with permission from “Glycemic and insulinemic response to ingestion of a novel food bar
containing when protein and isomalto-oligosaccharides” by Tyler Grubic et al. 2018. Austin Journal of 
Nutrition and Food Sciences, Vol. 6, pp 1-10, Copyright 2018 by Tyler Grubic. 
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Isomalto-oligosaccharides (IMO) is a prebiotic high fiber, low calorie source of 
carbohydrate that has been used as a functional food and prebiotic fiber sweetener in 
Asia for over 3 decades [205-209]. Basic animal studies indicate that IMO’s serve as a 
soluble dietary fiber and can stimulate activity of the probiotic gut flora, improve gut 
function, and help manage cholesterol in animals fed on a high fat diet [205, 208, 210-
212]. 
Given the interest in developing food and energy bars that provide quality protein 
with a low to moderate glycemic profile, we sought to determine the glycemic and 
insulinemic responses of ingesting a whey protein food bar with IMO as the source of 
carbohydrate. Our primary outcome was assessment of the glycemic insulinemic 
responses to ingesting this food bar (FB). The secondary outcome was assessment of 
how ingestion of this FB affected appetite related variables and subjective ratings of 
hypoglycemic symptoms. We hypothesized that ingestion of a mixed ingredient food bar 
containing IMO would promote a low to moderate glycemic response and positively 
affect perceptions about appetite with no evidence of hypoglycemia. 
Methods 
Experimental Design 
This study was conducted with approval by an Institutional Review Board 
(IRB2016-0830D) and was registered with clinicatrials.gov (#NCT03166514). This 
study was conducted in two parts at a university-based research setting in randomized, 




































































































































In both studies, the independent variable was nutrient intake and dependent 
variables included blood glucose, insulin, and subjective ratings related to appetite and 
hypoglycemic side effects.  
Participants  
Apparently healthy men and women between the ages 18–35 years with a body 
mass index (BMI) less than 25 kg/m2 were recruited to participate in this study. 
Individuals who expressed interest in participating were screened by phone to determine 
if they met initial eligibility to participate in this study. Qualified individuals were 
invited to attend a familiarization session in which participants received a written and 
verbal explanation of the study design, testing procedures, and read and signed informed 
consent statements. Those giving consent completed personal and medical histories and 
had height, weight, blood pressure, and heart rate determined. The research coordinator 
reviewed medical history forms, physical examination measurements, and determined 
eligibility to participate. Participants were excluded from the study if they reported: 1.) 
any uncontrolled metabolic disorders or cardiovascular disorder, including heart disease, 
a history of hypertension, diabetes, thyroid disease, hypogonadism; 2.) hepatorenal, 
musculoskeletal, autoimmune, or neurological disease; 3.) they were currently taking 
prescribed medication or dietary supplements for thyroid, hyperlipidemia, 
hypoglycemia, anti-hypertensive, anti-inflammatory, or weight loss (e.g. thermogenic 
compounds) within three months before the start of this study; or, 4.) had any known 
allergies to some of the nutrients contained in the food bar (i.e., almonds, milk, soy, 
peanuts, tree nuts, egg, and wheat).   
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Nutritional Intervention 
In a placebo controlled, counterbalanced, and crossover manner, participants 
ingested a carbohydrate and protein food bar (FB, FitJoy™, Nutrabolt, Bryan TX) 
containing 20 g of a whey protein blend, 25 g of carbohydrate (13 g fiber and 4 g of 
sugar) as IMO plant fiber (VitaFiber™, BioNutra North America, Inc. Edmonton, 
Alberta, Canada), and 7 g of fat (1.5 g saturated) or 25 g of dextrose (PLA, Valeant 
Pharmaceuticals North America LLC, Bridgewater, NJ, USA). After a 7 to 10-day 
washout period, participants repeated the experiment while ingesting the remaining 
nutrient. In Study 1, participants ingested one food bar (FB) containing 220 calories and 
one 25 g serving of the PLA providing 100 calories (i.e., typical serving size) while in 
Study 2 participants ingested two FB’s and two 25 g servings of the dextrose PLA in 
order to assess the glycemic responses to ingesting a standard oral glucose tolerance test 
dose (i.e., 50 g). Participants were given as much time as need to ingest the nutrients but 
this typically was less than 3-5 minutes. 
Testing Sequence 
Figure 1 presents the general experimental design employed in both studies. For 
each experiment, participants were instructed to refrain from exercise for 24 h and fast 
for 10 h prior to reporting to the lab for testing. Once arriving at the lab, body weight 
was determined, participants completed appetite and hypoglycemia symptom related 
questionnaires, and they donated a fasting blood sample. Participants then ingested their 
assigned nutrient and a timer was started. Blood samples were obtained at 10, 20, 30, 60, 
90 and 120 min post-ingestion while responses to questionnaires were obtained 60 and 
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120 minutes after ingestion of the assigned nutrient. Participants observed a 7 to 10-day 
washout period and then repeated the experiment in a crossover manner while ingesting 
the remaining nutrient.  
Procedures 
Anthropometrics  
Body weight and height was determined on a Healthometer Professional Scale 
model 500KL (Pelstar LLC, Alsip, IL, USA). Heart rate was taken at the radial artery 
and systolic and diastolic blood pressure was measured using standard procedures [213].  
Blood Collection Procedures 
Venous catheters were placed in the participant’s arm using a BD Insyte 
Autoguard 20 gauge intravenous (IV) catheter (Becton, Dickinson and Company, 
Franklin Lakes, NJ, USA) using standard procedures [214, 215]. Blood samples were 
collected in 8.5 mL BD Vacutainer® serum separation tubes (Becton, Dickinson and 
Company, Franklin Lakes, NJ, USA). Samples were left at room temperature for 15 min 
prior to being centrifuged at 3,500 rpm for 10 min using a refrigerated (4°C) Thermo 
Scientific Heraeus MegaFuge 40R Centrifuge (Thermo Electron North America LLC, 
West Palm Beach, FL, USA) [216]. Serum was then aliquoted into serum storage 
containers (Eppendorf North America, Inc., Hauppauge, NY, USA) and frozen at -80°C 
for subsequent analysis.   
Blood Chemistry Analysis 
Blood glucose was analyzed using a Cobas c111 (Roche Diagnostics, Basel, 
Switzerland) automated clinical chemistry analyzer. Quality control was performed daily 
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to determine whether the system calibrated to acceptable standards using two levels of 
controls. Serum samples were re-run if values were outside the control values or clinical 
normality. The test-to-test reliability of performing glucose analysis was 2.3±0.03% with 
a coefficient of variation (CV) of 1.1%. Insulin was assayed in duplicate by using an 
enzyme-linked immunosorbent assay (ELISA) kit (ALPCO, Salem, NH) and assaying 
samples with a BioTek ELX-808 Ultramicroplate reader set at an optical density of 450 
nm with BioTek Gen5 Analysis software (BioTek Instruments Inc., Winooski, VT). The 
intra-assay CV for insulin ranged from 2.9% to 6.2%. Glycemic Index (GI) was 
calculated using the integrated area under the curve (iAUC) change from baseline after 
FB ingestion divided by the iAUC of the dextrose PLA control normalized to 100 [217, 
218]. Glycemic load (GL) values were calculated as the product of the amount of 
available carbohydrate in the FB times the GI value divided by 100 [217, 218]. 
Side Effects and Eating Satisfaction Questionnaires 
Participants were asked to subjectively rate appetite, hunger, satisfaction from 
food, feelings of fullness, and amount of energy using a 0 to 10 Likert scale where 0 was 
none, 2.5 was low, 5 was moderate, and 7.5 was high, and 10 was severe.  Participants 
were also asked to rank the frequency and severity of their symptoms (i.e., 
hypoglycemia, dizziness, headache, fatigue, stomach upset) using the following scale: 0 
(none), 1-4 (light), 5-6 (mild), 7-9 (severe), or 10 (very severe).  
Statistical Analysis  
Data were analyzed using IBM® SPSS® Version 24 software (IBM Corp., 
Armonk, NY, USA). The sample size was based on prior research we conducted that 
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indicated an n-size of 10 – 20 would yield a power of 0.80 on changes in glucose and 
insulin in response to an oral glucose challenge [82, 83]. Baseline demographic data 
were analyzed using one-way ANOVA. Data were analyzed using univariate, 
multivariate and repeated measures general linear models (GLM) with and without 
gender as a covariate. Since no gender interactions were observed, we report GLM data 
without the covariate. Wilks’ Lambda multivariate tests are reported to describe overall 
effects of related variables analyzed. Greenhouse-Geisser univariate tests with least 
significant difference post-hoc comparisons are presented for individual variables 
analyzed. Delta changes (post-pre) were calculated and analyzed by one-way ANOVA 
post-hoc analyses. Data are reported as mean (SD) and mean change from baseline with 
95% confidence intervals (CI). Changes from baseline were calculated by integrated area 
under the curve (iAUC) using procedures previously described [219, 220]. Data were 
considered statistically significant when the probability of type I error was 0.05 or less. 
Mean changes with 95% CI’s completely above or below baseline were considered 
significantly different [221]. 
Results 
Participant Characteristics 
Figure 2 presents a CONSORT diagram for both studies. In study 1, a total of 31 
individuals met initial screening criteria and consented to participate in this study. A 
total of 20 completed the study. In Study 2, a total of 10 individuals met initial screening 
criteria and consented to participate in this study. A total of 10 completed the study. 
Table 1 presents participant demographics for the studies. In study 1, participants were 
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24.3±4.2 yr, 73.1±11.4 kg, and had a body mass index (BMI) of 22.6±3.2 kg/m2. Men 
were significantly taller, heavier, and had a higher BMI. In study 2, participants were 
26.3±3.2 yr, 73.1±11.4 kg, and had a BMI of 21.8±2.0 kg/m2 with men weighing more 
and having a higher BMI. 
Glucose and Insulin 
Table 1. Pharmacokinetic participant demographics. Reprinted with permission from (Grubic, 2018) 
Table 2 presents glucose and insulin data observed by treatment and gender in 
Study 1 and 2 while Figure 3 shows mean responses to the treatments over time. 
Multivariate analysis revealed overall Wilks' Lambda time (p<0.001) and treatment x 
time (p=0.003) effects in study 1 with no gender effects. Univariate analysis revealed 
significant time and treatment x time interactions in glucose responses. Post-hoc analysis 
revealed that while blood glucose levels increased in both groups, values in the FB 
treatment were significantly lower than PLA responses during the first 60 minutes after 
ingestion. Insulin levels increased over time with no significant differences observed 
between treatments. In study 2, multivariate analysis revealed overall Wilks' Lambda 
Male Female Mean p-Level Male Female Mean p-Level
N 10 10 6 4
Age (y) 25.1±3.1 23.5±5.0 24.3±4.2 0.230 26.2±4.2 26.4±3.2 26.3±3.2 0.894
Height (m) 1.63±0.04 1.52±0.05 1.57±0.04 0.001 1.73±0.07 1.70±0.08 1.72±0.08 0.417
Weight (kg) 70.9±4.7 60.6±7.8 73.1±11.4 0.001 76.6±9.0 66.9±12.6† 73.1±11.4 0.001
BMI (kg/m
2
) 23.6±1.3 21.7±1.7 22.6±3.2 0.001 20.8±1.5 22.8±2.2 21.8±2.0 0.023
Pharmacokinetic Participant Demographics
Study 1 Study 2
Data are mean ± SD.
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time (p=0.001) and treatment x time (p<0.001) effects. In both experiments, glucose and 
insulin levels peaked 30 minutes after ingestion. Figure 4 presents mean changes with 
95% CI’s for both studies. Glucose generally increased to a greater degree and for a 
longer period of time after ingesting the PLA. Interestingly, FB ingestion was only 
marginally increased from baseline for the first 30 minutes in Study 1 and 10 minutes in 
Study 2.  
The overall AUC for glucose was significantly lower in FB treatment in Study 1 
(FB 599±50, PLA 688±78 mmol-h/L, p<0.001) and Study 2 (530±48, PLA 697±67 
mmol-h/L, p<0.001). Using the Study 2 values, the FB GI was 76.7±10 with a GL of 
19.2±2.5. No significant differences were observed between treatments in the overall 
insulin AUC (Study 1: FB 2,136±1,073, PLA 1,848±971 µIU/mL-h/L, p=0.38; Study 2: 
FB 4,185±1,934, PLA 3,888±707 µIU/mL-h/L, p=0.65). 
Figure 5 presents iAUC changes from baseline for glucose and insulin. In both 
studies, the iAUC change from baseline was significantly greater after PLA ingestion 
(Study 1 FB 60 [CI 48, 71], 160 [134, 186], p<0.001; Study 2 FB 65 [49, 82], 209 [170, 
244] mmol-h/L, p<0.001). No significant differences were observed between treatments 
in insulin iAUC responses (Study 1: FB 1,436 [1,061, 1,811], PLA 1,302 [1,019, 1,585] 
µIU/mL-h/L, p=0.55; Study 2: FB 1,434 [917, 1,950], PLA 1,236 [842, 1,630] µIU/mL-
h/L, p=0.50). In comparison to consuming 50 g of dextrose normalized to 100, the FB 
had an iAUC derived GI of 34 [CI 23, 46] and a GL of 8.5 [CI 5.6, 11.6]. 
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Figure 3. Glucose and insulin values observed in study 1 and study 2 for the placebo (PLA) and Food Bar 





Table 2. Pharmacokinetic Study glucose and insulin response to an oral glucose challenge. Reprinted with 





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4. Mean changes with 95% CI’s in glucose (top panel) and insulin (bottom panel) during Study 1 
and Study 2 for the placebo (PLA) and Food Bar (FB) treatments. Confidence intervals crossing zero are 
statistically significant (p<0.05). * represents p<0.05 difference between PLA and FB. Reprinted with 





Figure 5. Integrated area under the curve (iAUC) change from baseline for glucose and insulin observed 
in Study 1 and Study 2 for the placebo (PLA) and Food Bar (FB) treatments. * represents p<0.05 
difference between PLA and FB.  Reprinted with permission from (Grubic, 2018). 
Finally, Table 3 presents responses to eating satisfaction questions. In both 
experiments, participants reported less subjective ratings of appetite, hunger, and greater 
satisfaction from food and feeling of fullness. Finally, no significant time, treatment, or 
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time by treatment effects were observed in subjective ratings of hypoglycemia, 
dizziness, headache, fatigue, or stomach upset.  
Discussion 
There is significant interest in developing low glycemic functional foods for 
consumers trying to maintain healthy blood glucose levels as well as athletes who want 
to consume low glycemic protein bars [77-80]. However, many protein and energy bars 
contain large amounts of carbohydrate and/or have a relatively high glycemic index, 
Therefore, these products may not be not suitable for individuals who are glucose 
intolerant and/or diabetic [79, 81] or for athletes who may be susceptible to 
hypoglycemia [77, 79, 80, 82, 83]. Isomalto-oligosaccharides is a prebiotic high fiber, 
low calorie source of carbohydrate that has been used in functional foods primarily in 
Asia [205-209]. Reports indicate that IMO serve as a soluble dietary fiber and prebiotic 
that can promote activity of the probiotic gut flora and improve gut function thereby help 
manage cholesterol [205, 208, 210-212]. The purpose of this study was to determine the 
glycemic and insulinemic response of ingesting a whey protein food bar with IMO as the 
source of carbohydrate. We hypothesized that ingestion of a mixed ingredient food bar 
containing IMO would promote a low to moderate glycemic response and positively 
affect perceptions about appetite with no evidence of hypoglycemia. 
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Table 3. Pharmacokinetic Study eating satisfaction inventory. Reprinted with permission from (Grubic, 
2018) 
Results of this study support this contention. In this regard, we found that the 
glycemic and insulinemic response of ingesting one and two servings of this FB were 
much more favorable than ingesting equivalent amounts of reference carbohydrate. 
Variable Treatment Effect p-Level
Appetite Time 5.77 ± 2.08 4.87 ± 1.90 † 5.40 ± 2.18 † Time 0.013
FB 6.40 ± 1.82 4.55 ± 1.76 † 4.65 ± 2.21 †* Treatment 0.001
PLA 5.15 ± 2.18 5.20 ± 2.02 6.15 ± 1.93 † Treatment x Time 0.001
Hunger Time 5.63 ± 2.11 4.75 ± 2.16 † 5.77 ± 1.92 Time 0.006
FB 5.80 ± 2.46 4.05 ± 2.06 †* 4.75 ± 1.83 †* Treatment 0.453
PLA 5.45 ± 1.73 5.45 ± 2.06 6.80 ± 1.40 † Treatment x Time 0.002
Satisfaction Time 0.53 ± 1.99 5.07 ± 2.38 † 4.52 ± 2.08 † Time 0.001
FB 0.55 ± 1.76 6.50 ± 1.57 †* 5.65 ± 1.50 †* Treatment 0.453
PLA 0.50 ± 2.24 3.65 ± 2.21 † 3.40 ± 1.98 † Treatment x Time 0.013
Fulllness Time 2.85 ± 2.08 5.05 ± 2.01 † 3.87 ± 2.10 † Time 0.001
FB 2.85 ± 2.11 5.85 ± 2.13 †* 5.15 ± 1.76 †* Treatment 0.453
PLA 2.85 ± 2.11 4.25 ± 1.55 † 2.60 ± 1.60 Treatment x Time 0.002
Energy Time 5.72 ± 1.71 6.03 ± 1.63 5.90 ± 1.32 Time 0.420
FB 5.55 ± 1.85 6.30 ± 1.49 6.20 ± 1.40 Treatment 0.077
PLA 5.90 ± 1.59 5.75 ± 1.74 5.60 ± 1.19 Treatment x Time 0.103
Appetite Time 5.80 ± 2.09 3.85 ± 2.32 † 5.10 ± 2.63 Time 0.009
FB 6.00 ± 2.71 2.80 ± 2.39 †* 3.60 ± 2.22 †* Treatment 0.001
PLA 5.60 ± 1.35 4.90 ± 1.79 6.60 ± 2.17 † Treatment x Time 0.020
Hunger Time 6.00 ± 1.97 3.75 ± 2.27 † 5.15 ± 2.87 † Time 0.002
FB 6.20 ± 2.30 2.50 ± 2.22 †* 3.50 ± 2.46 †* Treatment 0.453
PLA 5.80 ± 1.69 5.00 ± 1.56 6.80 ± 2.30 † Treatment x Time 0.009
Satisfaction Time 0.60 ± 1.43 4.40 ± 2.82 † 3.90 ± 2.81 Time 0.001
FB 0.40 ± 1.27 5.00 ± 2.91 † 4.90 ± 2.81 † Treatment 0.453
PLA 0.80 ± 1.62 3.80 ± 2.74 † 2.90 ± 2.56 † Treatment x Time 0.145
Fulllness Time 1.90 ± 1.83 5.35 ± 0.57 † 2.62 ± 3.80 † Time 0.001
FB 1.50 ± 1.72 6.50 ± 0.63 †* 2.55 ± 5.10 †* Treatment 0.453
PLA 2.30 ± 1.95 4.20 ± 0.54 † 2.25 ± 2.50 Treatment x Time 0.020
Energy Time 5.85 ± 1.84 6.15 ± 2.23 6.10 ± 1.71 Time 0.632
FB 6.40 ± 1.51 6.90 ± 1.45 6.80 ± 1.32 Treatment 0.077











Data are means ± standard deviations (SD) or standard error of the mean (SEM).  In study 1, multivariate analysis revealed 
overall Wilks' Lambda treatment (p<0.001), time (p=0.001), and treatment x time (p=0.008).   In study 2, multivariate analysis 
revealed overall Wilks' Lambda treatment (p<0.122), time (p=0.013), and treatment x time (p=0.424). Greenhouse-Geisser 
univariate p-levels are presented for each variable. PLA=Placebo, FB=Food Bar, M=male, F=female.  † denotes p<0.05  
difference from baseline.  * p<0.05 difference between PLA and FB.  




Analysis of iAUC changes from baseline which has been suggested to be a more 
accurate assessment of glycemic response to ingesting food [222, 223] indicated that the 
FB study had a low glycemic index (34 [CI 23, 46]) and glycemic load 8.5 [CI 5.6, 11.6] 
[222] when normalized to the dextrose reference. Glucose levels increased less than 15% 
from fasting values after FB ingestion compared to an increase of up to 73% with 
dextrose. Additionally, although the treatments differed in caloric content and sweetness 
which influence perceptions about appetite, hunger, and satiety [224]; ingestion of the 
energy/food bar also decreased perceptions of appetite and hunger and increase feelings 
of fullness with no symptoms associated with hypoglycemia. These findings indicate 
that the food bar studied may be a good food choice for individuals on low glycemic 
diets and/or trying to manage weight [225-232]. 
Interestingly, even though glucose levels were only modestly increased following 
FB ingestion, insulin levels increased in both groups with values generally higher 
following FB ingestion. There are several possible reasons for this finding. First, there is 
some evidence that amino acid ingestion can modestly increase insulin levels and that 
ingestion of protein or amino acids with carbohydrate may promote a greater effect [233-
236]. So, since the FB treatment contained 20 g of whey protein, this may have 
contributed to this finding. Second, although IMO is a prebiotic, it is a type of 
oligosaccharide that has been reported to stimulate growth of “friendly” bacteria and 
thereby promote activity of the probiotic gut flora and improve gut function [208, 237-
239]. Therefore, it is possible that intestinal absorption of glucose was enhanced thereby 
serving to help maintain blood glucose levels to a greater degree while the increased 
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availability of amino acids served to stimulate insulin levels. Additional research should 
examine potential mechanisms associated with these findings.  
It is also important to note that changes in blood glucose and insulin, 
macronutrient content of a food, portion size, perceptions about sweetness, and energy 
content of a food affect subjective ratings of satiety as well as secretion of appetite-
related hormones [240, 241]. Generally, hypoglycemia stimulates appetite and hunger 
while increases in blood glucose and insulin after consuming food reduces appetite and 
hunger. In this study, perceptions about appetite and hunger decreased while satisfaction 
with food and feelings of fullness increased to a greater degree with FB treatment 
despite blood glucose levels increasing by less than 15%. While this may simply be 
related to these other factors [240], it is interesting that these findings were observed 
with only a modest increase in blood glucose. Additional research is needed to examine 
how IMO and foods using IMO as a carbohydrate source influence satiety. 
The maintenance of blood glucose while observing a similar or higher increase in 
insulin also has some potential applications for individuals involved in exercise training. 
It is recommended that athletes consume low to moderate sources of carbohydrate with 
10 to 20 g of high quality protein prior to intense and prolonged exercise in order to 
maintain blood glucose availability, prevent hypoglycemia, minimize exercise induced 
protein degradation during exercise, and stimulate protein synthesis [77, 78, 80, 82]. 
However most commercially available energy/food bars contain large amounts of high 
glycemic carbohydrate and/or low amounts of quality protein which may not be optimal 
for athletes to ingest prior to exercise. Additionally, they are typically marketed as in-
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between meal snacks or meal replacements rather than to optimize nutrient availability 
around exercise [202]. The energy/food bar studied contains a low glycemic source of 
carbohydrate (IMO and plant fiber) and 20 g of high quality whey protein that would 
provide more than 6 g of essential amino acids (EAA). We found that this energy/food 
bar has a low GI, elicited only a modest increase in blood glucose levels, and promoted a 
similar increase in insulin as compared to a high GI carbohydrate (dextrose). 
Theoretically, this may serve as an optimal pre-exercise source of carbohydrate for 
active individuals because in can provide a more sustained release of glucose while 
stimulating insulin and thereby lessening exercise-induced catabolism during exercise 
[77, 78, 80, 82]. Additional research should evaluate whether ingestion of this 
energy/food bar prior to, during, and/or following intense exercise can help maintain 
blood glucose level, reduce markers of catabolism, and/or promote recovery. 
In conclusion, using IMO as a carbohydrate source in a protein energy/food bar 
promoted a significantly lower glycemic response while still stimulating insulin release. 
The protein/food bar had a low glycemic index (34 [CI 23, 46]) and glycemic load 8.5 
[CI 5.6, 11.6] [222] when normalized to the dextrose reference. It also reduced 
perceptions related to appetite with no effect on hypoglycemia related symptoms. Thus, 
this protein/food bar may serve as a low glycemic food option for individuals on a low 
glycemic diet or trying to maintain weight and/or athletes interested in optimizing 
nutrient availability around exercise. Additional research should evaluate the potential 
benefits of using IMO as a carbohydrate source in functional foods as well as other 
potential health effects of increasing dietary availability of IMO.   
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CHAPTER IV  
EXERCISE STUDY 
EFFECTS OF INGESTING A FOOD BAR CONTAINING WHEY PROTEIN AND 
ISOMALTO-OLIGOSACCHARIDES ON PERFORMANCE AND RECOVERY 
FROM AN ACUTE BOUT OF RESISTANCE-EXERCISE AND SPRINT 
CONDITIONING* 
Introduction 
Ingestion of carbohydrate and protein prior to, during, and/or following exercise 
has been reported to enhance energy substrate availability, sustain exercise performance, 
and promote recovery [77, 242]. For this reason, active individuals often ingest energy 
drinks, gels and/or bars prior to, during, and/or following exercise [77-79, 242]. 
However, most commercially available energy drinks, gels, and bars have a relatively 
high glycemic index (GI) and therefore may not be not suitable for individuals who are 
glucose intolerant, diabetic, or susceptible to hypoglycemia during exercise [77, 79, 82, 
83, 242]. There has been significant interest in identifying how carbohydrate protein, 
and/or amino acids consumption, influence exercise capacity and/or performance. 
Research has shown that different types of carbohydrate and protein can have varying 
effects on substrate availability, exercise metabolism, performance, and/or recovery.  
 
 
*This paper “Effects of ingesting a food bar containing whey protein and isomalto-oligosaccharides on 
performance and recovery from an acute bout of resistance-exercise and sprint conditioning” has been 
prepared and submitted for an invited special edition of Nutrients on “Integrated Role of Nutrition and 
Physical Activity for Lifelong Health”. 
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For example, we previously reported that ingestion of moderate to low GI 
carbohydrate gel during prolonged cycling maintained blood glucose and insulin levels 
to a greater degree than a higher GI gel [83]. Additionally, adding different types of 
carbohydrate with low to high GI’s to whey protein had differential effects on glucose 
and insulin responses following intense resistance-exercise [82]. Based on this type of 
research, it has been recommended that athletes consume low to moderate GI 
carbohydrate prior to and during exercise [77, 242]. Moreover, consuming whey protein 
and/or essential amino acids prior to, during, and/or following intense exercise can 
enhance protein synthesis [77, 242] 
Isomalto-oligosaccharides (IMO) is a prebiotic high fiber, low calorie source of 
carbohydrate that has been used as a functional food and prebiotic fiber sweetener in 
Asia for over 3 decades [205-209]. Basic animal studies indicate that IMO’s serve as a 
soluble dietary fiber and can stimulate activity of the probiotic gut flora, improve gut 
function, and help manage cholesterol in animals fed on a high fat diet [205, 208, 210-
212]. Given the interest in developing food and energy bars that provide quality protein 
with a low to moderate glycemic profile, we previously reported that ingesting a whey 
protein energy bar with IMO as the source of carbohydrate had a GI of 34 and a 
glycemic load of 8.5 [243]. Additionally, that ingesting this energy bar increased insulin 
to a greater degree while maintaining blood glucose compared to a dextrose control 
[243]. Theoretically, ingestion of this food bar prior to, during, and/or following intense 
exercise could maintain blood glucose and increase insulin levels during exercise, lessen 
the catabolic effects of intense exercise, and/or hasten recovery.  
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The purpose of this study was to determine if ingesting this low-glycemic food bar 
prior to, during, and following intense exercise would affect glucose homeostasis, 
exercise performance and/or recovery. The primary outcome measure was glucose 
homeostasis during and following exercise. Secondary outcome measures included 
assessment of performance, ratings of muscle soreness, markers of catabolism and 
inflammation, and subjective ratings of appetite, hypoglycemia, and readiness to 
perform. We hypothesized that ingestion of the FB studied would better maintain 
glucose homeostasis than placebo, better maintain exercise capacity during intense 
training, and hasten recovery.   
Materials and Methods 
Experimental Design 
This study was conducted at a university research setting with approval by an 
Institutional Review Board (IRB2017-0602) in compliance with the Declaration 
of Helsinki standards for ethical principles regarding human participant research and was 
registered with clinicatrials.gov (#NCT03704337). This study was conducted in a 
randomized, counter-balanced, crossover, and open label manner. The independent 
variable was nutrient intake. The primary outcome measure was glucose homeostasis as 
determined by assessing glucose and insulin responses. Secondary outcome measures 
included assessment of performance as determined by assessing resistance-exercise 
lifting volume, agility and sprint performance, and isokinetic strength; and, recovery as 
determined by assessing ratings of muscle soreness; markers of catabolism, stress, and 
inflammation; and, ratings of readiness to perform. Additionally, dietary energy and 
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macronutrient, subjective ratings of symptoms of hypoglycemia and subjective ratings of 
appetite and eating satisfaction were assessed.  
Participants 
Twelve highly-trained men between the ages 18–35 years with a body fat 
percentage (BF%) less than 25%, or body mass index (BMI) less than 25 kg/m2, were 
recruited to participate in this study. Participants were required to have the capability to 
bench press their body weight and barbell squat at least 1.5 times their body weight; 
have been engaged in a resistance training program involving upper and lower body 
exercises for the last year; and, involved in sprint conditioning training for the last six 
months. Individuals who expressed interest in participating in the study were screened 
by phone to determine if they met initial eligibility to participate in this study. Qualified 
individuals were invited to attend a familiarization session in which participants received 
a written and verbal explanation of the study design, testing procedures, and read and 
signed informed consent statements. Those giving consent completed personal, training, 
and medical histories and had a physical examination by a research assistant. The 
research coordinator reviewed medical history forms, physical examination 
measurements, and determined eligibility to participate. Participants were excluded from 
the study if they reported: 1.) any uncontrolled metabolic disorders or cardiovascular 
disorder, including heart disease, a history of hypertension, diabetes, thyroid disease, 
hypogonadism; 2.) hepatorenal, musculoskeletal, autoimmune, or neurological disease; 
3.) they were currently taking prescribed medication or dietary supplements for thyroid, 
hyperlipidemia, hypoglycemia, anti-hypertensive, anti-inflammatory, weight loss (e.g. 
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thermogenic compounds) within three months before the start of this study; 4.) had any 
known allergies to some of the nutrients contained in the food bar (i.e., almonds, milk, 
soy, peanuts, tree nuts, egg, and wheat); 5.) did not meet BF% or BMI criteria; or, 6.) did 
not meet bench press and/or squat one repetition maximum (1RM) criteria. Figure 6 
presents a Consolidated Standards of Reporting Trials (CONSORT) diagram for the 
study. A total of 43 individuals passed phone screens, 17 participants gave consent to 
participate in the study and underwent familiarization, 12 individuals met all screening 
criteria and were allocated to the study with all of these participants completed the study. 
Nutritional Intervention 
In a placebo controlled, counterbalanced, crossover, and open label manner; 
participants ingested 25 grams of dextrose gel (Valeant Pharmaceuticals North America 
LLC, Bridgewater, NJ, USA) which served as a carbohydrate-matched placebo (PLA) or 
a commercially-available food bar (FB, FitJoy™, Nutrabolt, Bryan TX) containing 20 g 
of a whey protein, 25 g of carbohydrate as IMO plant fiber (VitaFiber™, BioNutra 
North America, Inc. Edmonton, Alberta, Canada) consisting of 13 g fiber and 4 g of 
sugar, and 7 g of fat (1.5 g saturated fat) prior to, during, and following intense exercise. 
One FB contained 220 calories while the PL contained 100 calories of carbohydrate. 
Participants were given as much time as need to ingest the nutrients which typically 
lasted less than 3-5 minutes. The rationale in using a carbohydrate matched dextrose gel 
rather than a iso-caloric amount of carbohydrate is that athletes typically ingest 
carbohydrate drinks and/or gels prior to and during exercise so efficacy of the FB would 
need to be established compared to common practice; the amount of carbohydrate was 
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consistent with recommendations of the amount of carbohydrate per hour athletes should 
consume (i.e., 30 – 60 g/h or carbohydrate); providing an iso-caloric amount of 
carbohydrate gel to match the energy intake of the FB (i.e., 3 x 55 g per servings over a 
1.25 hr period of training) would have likely promoted hypoglycemia and impaired 
exercise performance; and, costs of manufacturing an energy bar containing all nutrients 
with a different source of carbohydrate for this initial exploratory study was cost 
prohibitive..After a 7-day washout period, participants repeated the experiment while 
ingesting the remaining nutritional intervention.  
Testing Sequence 
Figure 7 presents the general experimental design employed in this study. 
Participants were instructed to refrain from non-steroidal anti-inflammatory drug 
(NSAID) and pain relief medication for 48 h, exercise for 24 h, and fast for 10 h prior to 
reporting to the lab for testing. Once arriving at the lab participants completed appetite, 
hypoglycemia, and readiness to perform related questionnaires, and donated a fasting 
blood sample. Baseline ratings of pain to a standard amount of pressure applied to 
several locations on the thigh, isokinetic muscular strength and endurance 
measurements, and arterialized-venous glucose measurements from a finger were then 
obtained. Participants then ingested their assigned nutrient (PLA or FB) and rested 
passively for 30 min. Participants then completed a rigorous resistance-training exercise 
protocol consisting of 11 total upper and lower body exercises. Midway through the 
exercise session, participants ingested another serving of the PLA or FB. After the 
resistance-exercise was completed, participants performed three 40-yard (FYD) and 
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three repeated Nebraska Agility Drills (NAD) utilizing a 1:4 work to rest ratio. 
Arterialized-venous samples were also taken immediately before exercise, midway 
during resistance-exercise, following resistance-exercise, following performing the 
sprints, and following isokinetic testing. After completing the exercise bout, participants 
completed questionnaires, donated a venous blood sample, rated pain to standard 
pressure applied to the thigh, and performed isokinetic tests. Participants consumed a 
final serving of PLA or FB prior to leaving the lab and were instructed not to eat any 
additional food for another 2 h. Participants refrained from exercise and NSAID or pain 
relief medication during the 48-h recovery period. Participants then reported to the lab 
two days later after fasting for 10 h. Participants then donated a venous blood sample, 
rated pain to a standard amount of pressure applied to the thigh, and performed 
isokinetic testing. Participants observed a 7-day washout period and then repeated the 
experiment in a crossover manner while ingesting the alternative nutrient. 
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Body weight and height was determined on a Healthometer Professional Scale 
model 500KL (Pelstar LLC, Alsip, IL, USA). Heart rate was taken at the radial artery 
and systolic and diastolic blood pressure was measured using standard procedures [213]. 
Body composition was determined with a Hologic Discovery W Dual-Energy X-ray 
Absorptiometer (DXA; Hologic Inc., Waltham, MA, USA) equipped with APEX 
Software (APEX Corporation Software, Pittsburg, PA, USA). Test-retest reliability 
studies performed with this DXA machine have previously yielded mean coefficients of 
variation for bone mineral content and lean mass of 0.31-0.45% with a mean intra-class 
correlation of 0.985 [244].  
Dietary Assessment 
Participants were instructed to record all food and beverage intakes each week 
that they were involved within the study protocol on 4-day dietary food questionnaires (3 
weekdays, 1 weekend day), which is reflective of their average dietary intake on normal 
days. Food records were entered and analyzed with Food Processor Nutrition Analysis 
Software Version 11.2.285 (Esha Nutrition Research, Salem, OR) and analyzed for 
average energy and macronutrients by study researchers [245].  
Resistance Exercise Protocol 
During the familiarization testing session participants followed a protocol to 
determine 1RM for chest press, barbell squat, wide-grip latissimus dorsi (lat) pull, leg 
press, incline bench press, dumbbell lunges, seated row, leg extension, dumbbell curls, 
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triceps rope press-down, and biceps curls [246]. For exercises in which 1RM was 
exceeded by available weights, the Epley formula was used to predict the 1RM based on 
the number of repetitions performed at a given weight [247].  Rest periods between 
participants was not limited during 1RM determination so that the participants had 
sufficient opportunity to reach their true maximum weight, however participants were 
encouraged to try to reach their 1RM within 3-5 sets of their warmup set per agreement 
with NSCA 1RM testing protocols [248]. During the resistance exercise protocol, each 
participant performed three sets of 10 repetitions with approximately 70% of their 1RM 
for each of the 11 total exercises (i.e., chest press, barbell squat, wide-grip lat pull, leg 
press, incline bench press, lunges, seated row, leg extension, dumbbell curls, rope press-
down, and preacher curls) [246]. Each set was followed by a 2-minute rest period. All 
lifting was performed under the supervision of researchers and a certified strength and 
conditioning coach. If a participant could not complete the full 10 repetitions at the 70% 
1RM load, the weight was immediately reduced so that the 10 repetitions could be 
completed. The weight and the number of repetitions was recorded by researchers on 
each participant’s workout card immediately following each completed set, so that total 
lifting volume could later be calculated. Test-to-test reliability for total lifting revealed a 
mean Cv of 0.012 with a mean intraclass correlation of 0.996. 
Conditioning Drills 
Directly following the resistance-exercise protocol, each participant performed 
three 40-yard sprint trials separated by about 20-seconds of rest in between, to 
implement a 1:4 work to rest interval ratio. When ready, the participant lined up at the 
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starting line and was instructed to sprint as fast as they could all the way through the 
finish line. Participants were also instructed to start in a static position, but had the 
option to start in a three point stance or standing, and had to maintain the same starting 
position for each time-trial. The recorded time for the 40-yard dash began on the 
participant’s first motion forward and ended once the participant crossed the finish line 
at 40-yards [249-251]. The test was performed on the same gym floor for each 
participant with lines denoting start and stop points. Test-to-test reliability for the 40-
yard dash sprint times revealed a mean Cv of 0.184 with a mean intraclass correlation of 
0.916. Participants then performed three NAD agility tests. The NAD is designed to test 
agility and change of direction skills [252]. The test is set up using four cones. Two 
cones are set up in line with one another five yards apart. One set of cones are offset by 
one yard. Participants are asked to sprint 5-yd to the cone on the next line, change 
direction and sprint back to the next cone, change direction and sprint to the last cone. 
Timing began on the participant’s first motion forward and ended once the participant 
crossed the last cone. Each participant completed three trials of this drill for time, 
implementing a 1:4 work to rest ratio. Test-to-test reliability for the NAD sprint times 
revealed a mean Cv of 1.128 with a mean intraclass correlation of 0.792. 
Muscle Soreness Assessment 
A Commander algometer (JTECH Medical, Salt Lake City, UT, USA) was used 
to apply a standardized amount of pressure (50 N) applied to the distal medialis (VM) at 
25% of the distance from the patella to the greater trochanter near the hip and the distal 
vastus lateralis (DVL) at 25% and mid-lateral vastus medialis (MLVL) at 50% of the 
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distance between the patella to the greater trochanter. The three sites were marked with 
permanent ink to standardize the location of assessment. Participants were asked to sit 
with both legs straight on a bench while the algometer measurements were taken. 
Pressure was applied to each site for 3-sec [204]. Participants were asked to rate their 
perception of muscle soreness using a visual analog GPRS at each site. The GPRS 
consisted of a straight horizontal-line with no hash-markings and only wording beneath 
the line.  The line read from left-to-right “no pain, dull ache, slight pain, more slight 
pain, painful, very painful, and unbearable pain”. Participants were instructed to scribe 
one clear mark bisecting the line which represented their pain level the best for each of 
the three pressure application sites. A ruler was used to measure the participant’s mark 
from the left-to-right in cm and was recorded in the data as such numerical value. 
Testing order (i.e., VM, DVL, MLVL) was standardized across all testing sessions for 
all participants. Participants recorded their perceived level of soreness on the GPRS 
evaluation line before moving onto the next site. Test-to-test reliability for this protocol 
revealed a mean intraclass correlation of 0.90 [253]. 
Isokinetic Assessment 
Participants performed a maximum voluntary contraction (MVC) isokinetic knee 
extension and flexion protocol at a speed of 60 degrees/sec on their dominant leg using 
the Kin-Com 125AP Isokinetic Dynamometer (Chattanooga-DJO Global Inc., Vista, 
CA, USA). Body and knee positioning were pre-determined during a familiarization 
session, and recorded using standard procedures to accurately ensure testing was 
repeatable and to decrease any between-testing variability for all isokinetic tests 
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performed throughout the testing duration. Each participant went through a warm up 
protocol prior to testing by performing three sets of five repetitions of knee extension 
and flexion at approximately 50% of their MVC with one minute between sets. One 
minute after completing the final warm-up set, participants performed 3 MVC’s of knee 
extension and flexion [204]. Test to test variability of performing this test yielded mean 
Cv values ranging from 0.1041 to 0.1340 with mean intraclass correlations ranging from 
0.700 to 0.881 for leg extension variables and mean Cv values ranging from 0.098 to 
0.1389 with intraclass correlations ranging from 0.905 to 0.963 for leg flexion variables.  
Blood Collection and Analysis 
Arterialized-venous blood samples were obtained from a clean and dried finger 
and measured for blood glucose using an Accu-Check Aviva Plus Blood Glucose 
Monitoring System (Roche Diagnostics, Indianapolis, IN, USA). New test strips were 
used each new test for each participant as per instructions described in the user manual. 
Additionally, approximately 20 mL of venous blood was collected in 8.5 mL BD 
Vacutainer® serum separation tubes (Becton, Dickinson and Company, Franklin Lakes, 
NJ, USA) using standard procedures [214, 215]. Samples were left at room temperature 
for 15 min prior to being centrifuged at 3,500 rpm for 10 min using a refrigerated (4°C) 
Thermo Scientific Heraeus MegaFuge 40R Centrifuge (Thermo Electron North America 
LLC, West Palm Beach, FL, USA) [216]. Serum was aliquoted into serum storage 
containers (Eppendorf North America, Inc., Hauppauge, NY, USA) and frozen at -80°C 
for subsequent analysis. Serum markers of catabolism were analyzed using a Cobas c111 
(Roche Diagnostics, Basel, Switzerland) automated clinical chemistry analyzer. Quality 
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control was performed daily to determine whether the system calibrated to acceptable 
standards using two levels of controls. Serum samples were re-run if values were outside 
the control values or clinical normality. The test-to-test reliability of performing glucose 
analysis was 2.3±0.03% with a coefficient of variation (CV) of 1.1%. Serum insulin, 
testosterone, and cortisol were analyzed using an Immulite 2000 analyzer (Siemens 
Healthcare GmbH, Henkest, Erlangen, Germany). Serum inflammatory markers 
[interleukin-1β (IL-1β), IL-4, IL-6, IL-8, IL-13, tumor necrosis factor- α (TNF-α), 
interferon- γ (IFN-γ)] were measured using a MILLIPLEX Human High Sensitivity T-
Cell Magnetic Bead Panel kit (EMD Millipore Corporation, St. Charles, MO, USA). 
Cytokine and chemokine measurements were assed using a Luminex MagPix instrument 
((Luminex Corporation, Austin, TX, USA) which requires a minimum of 50 positive 
beads for each human sample. This instrument has been reported to be highly reliable 
and valid [254-257]. Controls and all samples were run in duplicate according to 
standard procedures to ensure validity. The CV’s for these assays ranged between 0.02 
to 1.73%.   
Questionnaires 
Participants were asked to subjectively rate appetite, hunger, satisfaction from 
food, feelings of fullness, and amount of energy using a 0 to 10 Likert scale where 0 was 
none, 2.5 was low, 5 was moderate, and 7.5 was high, and 10 was severe. Test to test 
variability of performing this survey yielded mean Cv’s ranging from 0.372 to 0.784 
with mean intraclass correlations ranging from 0.157 to 0.748 for the items on the 
survey. Participants were asked to rank the frequency and severity of their symptoms 
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(i.e., hypoglycemia, dizziness, headache, fatigue, stomach upset) using the following 
scale: 0 (none), 1-4 (light), 5-6 (mild), 7-9 (severe), or 10 (very severe). Test to test 
variability of performing this survey yielded mean Cv’s ranging from 0.731 to 1.246 
with mean intraclass correlations ranging from 0.507 to 0.882 for the items on the 
survey. Participants were also asked to rank their readiness to perform using the 
following scale: 1 (strongly disagree), 2 (disagree), 3 (neutral), 4 (agree), 5 (strongly 
agree). Test to test variability of performing this survey yielded mean Cv’s ranging from 
0.101 to 0.274 with mean intraclass correlations ranging from 0.026 to 0.881 for the 
items on the survey. 
Statistical Analysis 
Data were analyzed using IBM® SPSS® Version 25 software (IBM Corp., 
Armonk, NY, USA). The sample size was based on prior research we conducted that 
indicated an n-size of 10 – 20 would yield a power of 0.80 on changes in glucose and 
insulin in response to an oral glucose challenge [82, 83]. Baseline demographic data 
were analyzed using descriptive statistics. Data were analyzed using a treatment (2) x 
time point (3 or 6) general linear model (GLM) multivariate and univariate repeated 
measures analysis. Wilks’ Lambda p-levels from multivariate tests are reported to 
describe overall time and treatment x time interaction effects of variables analyzed. 
Greenhouse-Geisser univariate tests were run to assess time and treatment x time 
interaction effects of individual variables within the multivariate model. Data were 
considered statistically significant when the probability of type I error was 0.05 or less. 
Least significant difference post-hoc comparisons were used to assess differences among 
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treatments. Results with p-levels close to statistical significance (i.e., p>0.05 to p<0.10) 
are reported with partial eta-squared (η
2
) effect size where the magnitude of effect was 
defined as 0.01 = small, 0.06 = medium, 0.13 = large [219, 220]. Delta changes (post - 
pre values) and 95% confidence intervals (CI) were also calculated on the data. Mean 
changes with 95% lower and upper CI’s completely above or below baseline were 
considered significantly different.   
Results 
Participant Characteristics 
Table 4 presents participant demographics for the study. With the crossover 






Age (y) 22.0 ± 1.8
Height (m) 1.78 ± 0.06
Weight (kg) 82.8 ± 10.4
Body Fat (%) 14.2 ± 3.8
Body Mass Index (kg/m2) 26.3 ± 3.8
HR (bpm) 61.8 ± 8.5
BP Systolic (mmHg) 119.0 ± 8.8
BP Diasystolic (mmHg) 71.8 ± 5.5
Bench 1RM (kg) 103.0 ± 18.0
Squat 1RM (kg) 139.5 ± 23.6
Relative Bench Ratio 1.24 ± 0.2
Relative Squat Ratio 1.69 ± 0.2
Mean
Table 4. Baseline participant demographics.
Data are mean ± SD.  
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Dietary Analysis 
Table 5 presents energy and macronutrient intake data. Multivariate analysis 
revealed no significant overall Wilks’ Lambda for time (p=0.508) or treatment x time 
(p=0.695). Likewise, univariate analysis revealed no statistically significant interactions 
among treatments. 
Glycemic and Insulinemic Response 
Table 6 shows serum glucose and insulin data observed by treatment. 
Multivariate analysis revealed an overall Wilks' Lambda time (p<0.001) and treatment x 
time interaction (p=0.007) effects. Univariate analysis revealed significant time 
(p<0.001) but not treatment x time interactions in glucose and insulin responses. Insulin 
levels increased over time with no significant differences observed between treatments, 
although insulin was 38% higher immediately following exercise in the FB group (PLA 
11.18±2.69, FB 15.49±2.6 uIU/mL, p=0.269, η
2
=0.06). Univariate analysis for the
Table 5. Energy and macronutrient intake.
Nutrients p-Level
Calories (kcal) 2248 ± 462 2252 ± 668 2534 ± 603 0.157
Protein (g) 133 ± 35 130 ± 38 146 ± 45 0.337
Carbohydrates (g) 213 ± 68 221 ± 100 243 ± 58 0.408
Fat (g) 88.6 ± 18.7 83.6 ± 40.0 99.8 ± 38.1 0.260
Baseline PLA FB
Data are means ± standard deviations (SD) or standard error of the mean 
(SEM).  A multivariate analysis revealed no overall Wilks' Lambda time 
(p=0.508) or treatment x time (p=0.695) effects. Greenhouse-Geisser 
univariate p-levels are presented for each variable. PLA=Placebo, FB=Food 
Bar.
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insulin to glucose ratio (IGR) showed a significant effect for time (p<0.001) and 
treatment x time (p=0.008). Post-hoc analysis revealed that the IGR significantly 
differed between treatments after exercise. 
Figure 8 shows mean changes from baseline with 95% CI’s in glucose, insulin, 
and IGR.  Glucose levels after 48-h after recovery tended to be lower in FB (PLA 0.23 [-
0.002, 0.46]; FB -0.05 [-0.28, 0.18] mmol/L, p=0.087, η
2
=0.13). Insulin was
significantly increased above baseline values after exercise in both groups with no 
differences observed between treatments (PLA 4.73 [0.33, 9.14], FB 9.22 [4.82, 13.62], 
p=0.149, η
2
=0.09). IGR was also significantly higher in both groups post-exercise when
compared to baseline, with FB being significantly higher between groups (PLA 0.04 
[0.00, 0.08], FB 0.11 [0.07, 0.15], p=0.013, η2=0.25). No differences were seen between 
Table 6.   Glucose and insulin response to an oral treatment during intense exercise.
Variable Treatment Effect p-Level
Glucose PLA 5.12 ± 0.48 5.05 ± 1.52 5.35 ± 0.40 Time 0.161
(mmol/L) FB 5.34 ± 0.40 4.81 ± 0.84 5.29 ± 0.47 Treatment x Time 0.447
Time 5.23 ± 0.45 4.93 ± 1.21 5.32 ± 0.43
Insulin PLA 6.44 ± 3.44 11.18 ± 9.59 † 7.72 ± 3.60 Time <0.001
(µIU/mL) FB 6.27 ± 3.77 15.49 ± 9.05 † 6.41 ± 3.77 Treatment x Time 0.129
Time 6.36 ± 3.53 13.33 ± 9.38 † 7.07 ± 3.67
PLA 0.070 ± 0.039 0.110 ± 0.072 † 0.080 ± 0.037 Time <0.001
FB 0.065 ± 0.039 0.173 ± 0.085 †^0.067 ± 0.038 Treatment x Time 0.008




Data are means ± standard deviations (SD) or standard error of the mean (SEM).  A multivariate 
analysis revealed overall Wilks' Lambda time (p<0.001) and treatment x time (p=0.007) effects. 
Greenhouse-Geisser univariate p-levels are presented for each variable. PLA=Placebo, FB=Food 
Bar. † denotes p<0.05  difference from baseline.   ̂represents p>0.05 to p<0.10 difference between 
PLA and FB.  
Fasted 48-h RecoveryPost-Exercise
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groups in area under the curve. 
Figure 8. Mean changes with 95% CI in blood glucose (top panel), insulin (center panel), and the 
insulin to glucose ratio (bottom panel) observed in the placebo (PLA) and food bar (FB) treatments. Mean 
changes from baseline with 95% CI’s completely above or below baseline represent a significant 
difference. † represents p<0.05 difference between treatments. ‡ represents p>0.05 to p<0.10 difference 
between treatments.  
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Figure 8. Continued. 
Figure 9 presents mean changes with 95% CI’s for glucose observed during the 
exercise sessions. Univariate analysis revealed significant time (p<0.001) and group x 
time interaction effects (p<0.001). Blood glucose generally increased to a greater degree 
and for a longer period of time after ingesting the PLA. Interestingly, glucose values 
remained within normal values (5.3±0.6 to 6.2±1.0 mmol/L) throughout the entire 
resistance-training and sprint protocol in the FB treatment while greater variability was 
seen with PLA (5.3±1.1 to 8.4±1.6 mmol/L). 
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Figure 9. Mean changes with 95% CI in blood glucose observed in the placebo (PLA) and food bar (FB) 
treatments. RE=resistance exercise. Mean changes from baseline with 95% CI’s completely above or 
below baseline represent a significant difference.* represents p<0.05 difference from baseline. † represents 
p<0.05 difference between treatments.    
Resistance Exercise Performance 
Table 7 presents volume of each of the upper and lower body resistance-exercises 
performed in the study. Multivariate analysis revealed an overall Wilks' Lambda time 
effect (p<0.010) with no treatment x time interaction effect (p=0.808). Univariate 
analysis revealed significant time effect for incline bench press (p<0.002), dumbbell 
biceps curl (p=0.001), and preacher curl (p=0.032) but no significant treatment x time 
interaction effects in among these exercises. 
Figure 10 presents mean changes from baseline with 95% CI’s for leg press and 
total lifting volume. Leg press volume significantly decreased from set 1 to Set 2 and Set 
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3 in the PLA treatment while participants in the FB treatment were able to maintain leg 
press lifting volume from Set 1 to Set 3. Post-hoc analysis revealed that leg press lifting 
volume tended to be lower with PLA compared to FB during set 2 (PLA -42.71 [-76.77, 
-8.65]; FB 0.00 [-34.06, 34.06] kg, p=0.08, η
2
=0.13) and set 3 (PLA -130.79 [-235.02, -
26.55]; FB -7.94 [-112.17, 96.30] kg, p=0.09, η
2
=0.12) when compared to baseline.
Similarly, participants maintained total lifting volume to a greater degree in Set 2 (PLA -
66.9 [-111.4, -22.4], FB -28.9 [-73.4, 15.6] kg, p=0.224, η
2
=0.07) and Set 3 (PLA -
198.26 [-320.1, -76.4], FB -81.7 [-203.6, 40.1] kg, p=0.175, η
2
=0.08) with FB treatment
compared to PLA. This represented a -3.12% [-5.11, -1.14] reduction in performance in 
the PLA treatment compared to a -1.28% [-3.27, 0.71] reduction in performance in the 




Table 7. Resistance exercise lifting volume.
Variable Treatment Effect p-Level
PLA 718 ± 125 718 ± 125 712 ± 121 Time 0.103
FB 718 ± 125 718 ± 125 716 ± 126 GxT 0.364
Mean 718 ± 122 718 ± 122 714 ± 121
PLA 979 ± 164 979 ± 164 979 ± 164 Time 1.000
FB 979 ± 164 979 ± 164 979 ± 164 GxT 1.000
Mean 979 ± 160 979 ± 160 979 ± 160
PLA 567 ± 82 567 ± 82 565 ± 84 Time 0.171
FB 567 ± 82 567 ± 82 565 ± 84 GxT 1.000
Mean 567 ± 80 567 ± 80 565 ± 83
PLA 1916 ± 502 1874 ± 485 1786 ± 490 Time 0.064
FB 1916 ± 502 1916 ± 502 1908 ± 500 GxT 0.101
Mean 1916 ± 490 1895 ± 483 1847 ± 488
PLA 557 ± 113 552 ± 115 538 ± 115 Time 0.002
FB 586 ± 108 576 ± 106 546 ± 120 GxT 0.291
Mean 571 ± 109 564 ± 109 542 ± 115 †
PLA 314 ± 146 312 ± 149 312 ± 149 Time 0.401
FB 355 ± 92 355 ± 92 363 ± 80 GxT 0.282
Mean 335 ± 121 334 ± 123 337 ± 120
PLA 612 ± 104 601 ± 104 591 ± 111 Time 0.242
FB 633 ± 75 633 ± 75 631 ± 77 GxT 0.324
Mean 623 ± 89 617 ± 90 611 ± 96
PLA 588 ± 244 584 ± 243 584 ± 243 Time 0.328
FB 699 ± 138 699 ± 138 699 ± 138 GxT 0.328
Mean 644 ± 202 642 ± 202 642 ± 202
PLA 132 ± 45 130 ± 42 122 ± 42 Time 0.001
FB 151 ± 18 140 ± 25 129 ± 32 GxT 0.199
Mean 142 ± 35 135 ± 34 † 125 ± 37 †
PLA 227 ± 57 229 ± 54 228 ± 55 Time 0.413
FB 234 ± 46 233 ± 47 230 ± 48 GxT 0.200
Mean 230 ± 50 231 ± 49 229 ± 51
PLA 222 ± 55 219 ± 54 218 ± 54 Time 0.032
FB 229 ± 45 223 ± 51 220 ± 53 GxT 0.492
Mean 226 ± 50 221 ± 51.5 † 219 ± 53 †
PLA 6832 ± 1145 6765 ± 1162 6634 ± 1245 Time 0.012
FB 7069 ± 1103 7040 ± 1115 6987 ± 1147 GxT 0.407
Mean 6951 ± 1106 6903 ± 1122 6811 ± 1185







Data are means ± standard deviations (SD) in lifting volume (repetitionx x weight 
lifted in kg)or standard error of the mean (SEM).  A multivariate  analysis revealed 
overall Wilks' Lambda time (p=0.010) and treatment x time (p=0.808).  Greenhouse-
Geisser univariate  p-levels are presented for each variable . PLA=Placebo, FB=Food 

















Figure 10. Mean changes with ± 95% confidence intervals in leg press volume (top panel) and total lifting 
volume (bottom panel) for the placebo (PLA) and food bar (FB) during exercise. Mean changes from 
baseline with 95% CI’s completely above or below baseline represent a significant difference. ‡ represents 
p>0.05 to p<0.10 difference between treatments. 
Sprint Performance 
Table 8 presents performance times observed for the agility and sprint tests. 
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Multivariate analysis revealed a significant overall Wilks’ Lambda for time (p<0.001) 
with no significant interaction effects (p=0.437). Univariate analysis revealed a 
significant time effect for agility performance (p<0.001) but not for 40-yd sprint 
performance (p=0.252). No significant interaction effects were seen in either agility or 
sprint performance. Figure 6 presents mean changes from baseline with 95% CI’s for 
agility performance. Results revealed that agility performance in sprint 2 were 
significantly faster than baseline times during the FB treatment (PLA -0.13 [-0.28, 0.02]; 
FB -0.21 [-0.36, -0.06] sec, p=0.422, η
2
=0.03) while both treatments were significantly
faster than baseline values during sprint 3. No significant time or between group 
differences were observed for 40 yard dash results, although it should be noted that 
participants performed the first 40 yard dash sprint -0.15 sec faster (-2.7%) with FB 




Table 8. Sprint performance. 
Variable Treatment Effect p-Level
PLA 7.01 ± 0.68 6.89 ± 0.49 6.74 ± 0.45 Time <0.001
FB 7.02 ± 0.46 6.81 ± 0.43 6.71 ± 0.46 GxT 0.670
Mean 7.01 ± 0.57 6.85 ± 0.45 † 6.73 ± 0.44 †
PLA 5.50 ± 0.38 5.41 ± 0.32 5.39 ± 0.24 Time 0.252
FB 5.35 ± 0.25 5.33 ± 0.19 5.36 ± 0.24 GxT 0.208
Mean 5.42 ± 0.32 5.37 ± 0.26 5.37 ± 0.24
Sprint-1 Sprint-2 Sprint-3
Data are means ± standard deviations (SD) or standard error of the mean (SEM).  A multivariate 
analysis revealed overall Wilks' Lambda time (p<0.001) and treatment x time (p=0.437) effects. 
Greenhouse-Geisser univariate p-levels are presented for each variable. PLA=Placebo, FB=Food 
Bar, GxT= treatment x time interaction.  † denotes p<0.05 difference from baseline.  





Figure 11. Mean changes with ± 95% confidence intervals in Nebraska Agility Drill performance times 
for the placebo (PLA) and food bar (FB) during exercise. Mean changes from baseline with 95% CI’s 
completely above or below baseline represent a significant difference. 
Isokinetic Maximal Voluntary Contraction (MVC) Performance 
Table 9 displays the torque, force, power, and total work performed during the 3-
repition isokinetic maximal voluntary extension/flexion contractions. Multivariate 
analysis revealed no significant overall Wilks’ Lambda time (p=0.352) or treatment x 
time (p=0.837) effects. Likewise, univariate analysis did not reveal any time or treatment 
x time effects for extension or flexion MVC torque, force, power, or total work. 
Assessment of mean changes from baseline with 95% CI’s did not reveal any significant 




Muscle Soreness Assessment 
 Table 10 presents subjective ratings of muscle soreness. Multivariate analysis 
revealed a significant overall Wilks' Lambda time effect (p<0.001) with no significant 
interaction effects (p=0.538). Univariate analysis showed a significant time effect for 
VM (p<0.001), DVL (p=0.002) and MLVL (p=0.004) with no significant interaction 
102 
effects. Figure 12 displays the mean change from baseline with 95% CI’s for ratings of 
muscle soreness. Ratings of VM muscle soreness after the workout were higher with 
PLA (PLA 1.88 [0.60, 3.17]; FB 0.29 [-0.99, 1.57] cm, p=0.083, η
2
=0.13). Additionally,
ratings of muscle soreness at the DVL (PLA 2.13 [0.45, 3.80]; FB 1.45 [-0.22, 3.12] cm, 
p=0.560, η
2
=0.02) and MLVL (PLA 2.32 [0.51, 4.12]; FB 1.53 [-0.28, 3.33] cm,
p=0.527, η
2
=0.02) sites remained above baseline values after 48 h recovery with PLA
treatment while ratings with FB treatment were not significantly different from baseline 
values. 
Table 10. Perception of quadricep muscle soreness.
Variable Treatment Effect p-Level
PLA 3.31 ± 2.51 5.19 ± 3.39 6.64 ± 2.78 Time <0.001
FB 4.09 ± 2.50 4.38 ± 2.76 6.28 ± 2.50 GxT 0.340
Mean 3.70 ± 2.48 4.79 ± 3.05 † 6.46 ± 2.60 †
PLA 3.64 ± 2.59 3.32 ± 2.89 5.77 ± 3.33 Time 0.002
FB 2.35 ± 1.99 2.51 ± 2.32 3.80 ± 3.59 GxT 0.489
Mean 3.00 ± 2.35 2.91 ± 2.60 4.78 ± 3.53 †
PLA 2.47 ± 2.49 3.00 ± 3.22 4.78 ± 3.34 Time 0.004
FB 1.93 ± 2.41 2.77 ± 2.58 3.46 ± 3.10 GxT 0.493
ean 2.20 ± 2.41 2.88 ± 2.85 4.12 ± 3.22 †
Data are means ± standard deviations (SD) or standard error of the mean (SEM).  A multivariate analysis 
revealed overall Wilks' Lambda time (p<0.001) and treatment x time (p=0.538) effects. Greenhouse-Geisser 
univariate p-levels are presented for each variable. PLA=Placebo, FB=Food Bar, GxT= treatment x time 
interaction. † denotes p<0.05  difference from baseline.  
Mid-Lateral Vastus 
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Figure 12. Mean changes from baseline with 95% confidence intervals in ratings of muscle soreness for 
the distal vastus medialis (top panel), distal vastus lateralis (center panel), and mid-lateral vastus lateralis 
(bottom panel) for the placebo (PLA) and food bar (FB) treatments. Mean changes from baseline with 
95% CI’s completely above or below baseline represent a significant difference. ‡ represents p>0.05 to 
p<0.10 difference between treatments. 
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Figure 12. Continued. 
Markers of catabolism 
Table 11 presents the serum markers of catabolism. Multivariate analysis revealed 
a significant overall Wilks’ Lambda time effect (p<0.001) with no significant interaction 
effects (p=0.360). Univariate analysis demonstrated significant effects over time for 
blood urea nitrogen (p<0.001), creatinine (p<0.001), lactate dehydrogenase (p<0.001), 
creatine kinase (p=0.038), and the blood urea nitrogen to creatinine ratio (p=0.001). 




Stress and Sex Hormones 
 Table 12 displays the serum stress and sex hormones. Multivariate analysis 
revealed an overall Wilks’ Lambda time effecc (p<0.001) with no significant treatment x 
time interaction effects were observed (p=0.914). Univariate analysis revealed a 
significant time effect for testosterone (p<0.001) with no other time or interaction effects 
observed. Assessment of mean changes from baseline with 95% CI’s revealed that 
cortisol levels tended to be lower with FB treatment compared to the PLA at 48-h 
recovery (PLA 0.35 [-1.18, 1.88]; FB -1.38 [-2.90, 0.15] ug/dL, p=0.111, η
2
=0.11). No 
significant differences were observed in changes in testosterone or the cortisol to 
testosterone ratio between treatments.  
Table 11. Markers of catabolism.  
Variable Treatment Effect p-Level
PLA 6.60 ± 1.79 6.39 ± 1.54 5.38 ± 1.76 Time <0.001
FB 6.61 ± 1.97 6.77 ± 1.71 5.72 ± 1.25 GxT 0.564
Mean 6.61 ± 1.84 6.58 ± 1.60 5.55 ± 1.50 †
PLA 94.7 ± 14.9 112.1 ± 22.2 97.8 ± 10.9 Time <0.001
FB 95.1 ± 15.6 108.7 ± 18.0 91.8 ± 15.2 GxT 0.382
Mean 94.9 ± 14.9 110.4 ± 19.8 † 94.8 ± 13.3
PLA 150 ± 21 172 ± 31 153 ± 23 Time <0.001
FB 149 ± 15 176 ± 30 153 ± 18 GxT 0.675
Mean 149 ± 18 174 ± 30 † 153 ± 20
PLA 289 ± 229 446 ± 232 480 ± 644 Time 0.038
FB 221 ± 104 396 ± 144 428 ± 374 GxT 0.940
Mean 255 ± 177 421 ± 191 † 454 ± 516 †
PLA 14.35 ± 3.72 11.95 ± 3.42 11.26 ± 3.62 Time 0.001
FB 14.25 ± 3.92 12.96 ± 3.58 13.10 ± 3.98 GxT 0.166
Mean 14.30 ± 3.73 12.46 ± 3.46 † 12.18 ± 3.84 †
Fasted Post-Exercise 48-hr Post
Data are means ± standard deviations (SD) or standard error of the mean (SEM).  A multivariate analysis 
revealed overall Wilks' Lambda time (p<0.001) and treatment x time (p=0.360) effects. Greenhouse-Geisser 
univariate p-levels are presented for each vareiable.  GxT represents group x time interaction. † denotes 
p<0.05  difference from baseline.  
Creatine Kinase                                       
(U/L)
LDH               
(U/L)
BUN/Creatinine 
Ratio                  
Urea/BUN                    
(mmol/L)
Creatinine                            
(umol/L)
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Inflammatory Marker Response 
Table 13 presents the serum inflammatory markers analyzed. Multivariate analysis 
revealed a significant overall Wilks’ Lambda for time (p=0.037) but not for treatment x 
time (p=0.985). Univariate analysis revealed a time effect for IL-8 (p=0.001) and TNFα 
(p=0.044) with no significant interaction effects observed. Assessment of mean changes 
from baseline with 95% CI’s revealed that IL-8 was higher than baseline values 
following exercise with FB treatment (PLA 0.54 [-0.07, 1.15]; FB 0.67 [0.06, 1.28] 
pg/mL, p=0.761, η
2
=0.01) with no differences observed between treatments. No other
differences from baseline or between treatments were observed among markers of 
inflammation. 
Table 12. Stress and sex hormone response. 
Variable Treatment Effect p-Level
PLA 15.5 ± 2.0 14.2 ± 5.7 15.9 ± 2.5 Time 0.403
FB 16.6 ± 1.8 14.9 ± 6.3 15.3 ± 2.4 GxT 0.644
Mean 16.1 ± 1.9 14.6 ± 5.9 15.6 ± 2.4
PLA 495 ± 161 401 ± 192 466 ± 163 Time <0.001
FB 503 ± 187 376 ± 186 458 ± 194 GxT 0.635
Mean 499 ± 171 389 ± 185 † 462 ± 175
PLA 28.0 ± 11.5 33.6 ± 20.2 29.4 ± 8.8 Time 0.112
FB 28.7 ± 8.0 36.2 ± 16.8 29.0 ± 8.9 GxT 0.819
Mean 28.3 ± 9.7 34.9 ± 18.2 29.2 ± 8.7
Data are means ± standard deviations (SD) or standard error of the mean (SEM).  A 
multivariate analysis revealed overall Wilks' Lambda time (p<0.001) and treatment x time 
(p=0.914) effects. Greenhouse-Geisser univariate p-levels are presented for each variable. 
PLA=Placebo, FB=Food Bar.  GxT represents group x time interaction. † denotes p<0.05  













Appetite, Hypoglycemia, and Readiness to Perform Assessment 
 Tables 14-16 present appetite and eating satisfaction, symptoms of hypoglycemia, 
and readiness to perform survey results, respectively. Multivariate analysis of responses 
to the eating satisfaction inventory questions revealed significant time (p=0.007) with no 
significant interaction effects (p=0.152). Univariate analysis revealed that ratings of 
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appetite and hunger declined while feelings of fullness increased over time. A significant 
interaction effect was observed in feeling of fullness with food (p=0.032) while ratings 
of hunger (p=0.094) and satisfaction (p=0.085) tended to differ among treatments. 
Assessment of mean changes from baseline with 95% CI’s revealed that hunger 
decreased below baseline values with FB treatment at the midway point of exercise 
(PLA -1.17 [-2.65, 0.31]; FB -3.33 [-4.81, -1.85] p=0.043, η
2
=0.17) and after exercise
(PLA -0.75 [-2.32, 0.82]; FB -2.42 [-3.99, -0.85] p=0.134, η
2
=0.10). Ratings of appetite
were than baseline values with FB treatment after exercise (PLA -0.67 [-2.19, 0.85]; FB 
-1.92 [-3.44, -0.40] p=0.240, η
2
=0.06). In terms of symptoms of hypoglycemia, a
significant overall Wilks’ Lambda time effect (p<0.001) was observed with no 
significant interaction effect (p=0.269). Univariate analysis revealed a time effect for 
hypoglycemia (p=0.001), dizziness (p=0.001), fatigue (p<0.001), and stomach upset 
(p=0.004). However, no significant interaction effects were observed in ratings of 
symptoms of hypoglycemia, dizziness, headache, fatigue, or stomach upset. Finally, 
analysis of responses to the readiness to perform questionnaire revealed an overall 
Wilks’ Lambda time effect (p=0.001) with no significant interaction effects (p=0.186). 
Univariate analysis revealed a significant time effects for feelings of vigor and energy 
(p=0.004), appetite (p=0.035), and muscle soreness (p=0.007) with no significant 
treatment x time interactions observed. Assessment of mean changes from baseline with 
95% CI’s revealed that response to the question “I have little muscle soreness” were 
significantly decreased below baseline values with PLA treatment (PLA -1.00 [-1.80, -
0.20]; FB -0.50 [-1.30, 0.30] p=0.368, η
2
=0.04) as well as after 48 h of recovery (PLA -
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1.00 [-1.91, -0.10]; FB -0.75 [-1.66, 0.16] p=0.689, η
2
=0.01) suggesting a greater
perception of muscle soreness. 
Table 14.  Appetited and Eating Satisfaction Inventory
Variable Treatment Effect p-Level
Appetite PLA 6.08 ± 3.09 4.00 ± 3.54 5.42 ± 3.26 Time <0.001
FB 6.92 ± 1.93 4.50 ± 1.73 5.00 ± 1.91 GxT 0.430
Mean 6.50 ± 2.55 4.25 ± 2.74 * 5.21 ± 2.62 *
Hunger PLA 6.00 ± 3.13 4.83 ± 3.13 5.25 ± 3.33 Time <0.001
FB 7.17 ± 2.21 3.83 ± 2.44 4.75 ± 1.86 GxT 0.094
Mean 6.58 ± 2.72 4.33 ± 2.79 * 5.00 ± 2.65 *
Satisfaction PLA 3.58 ± 2.81 2.00 ± 1.65 2.33 ± 1.92 Time 0.656
FB 2.58 ± 3.32 3.83 ± 3.01 4.67 ± 2.93 GxT 0.085
Mean 3.08 ± 3.05 2.92 ± 2.55 3.50 ± 2.70
Fulllness PLA 2.33 ± 2.57 2.42 ± 2.31 2.50 ± 2.71 Time 0.017
FB 2.17 ± 2.33 4.83 ± 2.59 *† 5.08 ± 2.07 *† GxT 0.032
Mean 2.25 ± 2.40 3.63 ± 2.70 * 3.79 ± 2.70 *
Energy PLA 5.33 ± 1.72 4.17 ± 1.70 5.33 ± 1.61 Time 0.192
FB 5.50 ± 2.07 5.58 ± 1.62 6.00 ± 2.13 GxT 0.357
Mean 5.42 ± 1.86 4.88 ± 1.78 5.67 ± 1.88
Fasted Post-ExerciseMid-Exercise
Data are means ± standard deviations (SD) or standard error of the mean (SEM).  A 
multivariate analysis revealed overall Wilks' Lambda time (p=0.007) and treatment x time 
(p=0.152) effects.  Greenhouse-Geisser univariate p-levels are presented for each variable. 
PLA=Placebo, FB=Food Bar, GxT represents group x time interaction.  * denotes p<0.05  
difference from baseline.  † p<0.05 difference between PLA and FB.  
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Table 15.  Symptoms Hypoglycemia Inventory
Variable Treatment Effect p-Level
Hypoglycemia PLA 0.83 ± 2.04 1.67 ± 1.87 1.00 ± 1.76 Time 0.001
FB 0.58 ± 0.90 2.08 ± 2.02 0.92 ± 1.56 GxT 0.465
Mean 0.71 ± 1.55 1.88 ± 1.92 * 0.96 ± 1.63
Dizziness PLA 0.83 ± 2.04 1.25 ± 1.66 0.50 ± 1.24 Time 0.001
FB 0.33 ± 0.78 2.00 ± 2.04 0.58 ± 1.24 GxT 0.095
Mean 0.58 ± 1.53 1.63 ± 1.86 * 0.54 ± 1.22
Headache PLA 0.33 ± 0.65 0.67 ± 1.15 0.50 ± 0.90 Time 0.384
FB 0.17 ± 0.39 0.33 ± 0.89 0.33 ± 0.89 GxT 0.804
Mean 0.25 ± 0.53 0.50 ± 1.02 0.42 ± 0.88
Fatigue PLA 1.75 ± 2.22 4.25 ± 2.56 3.67 ± 2.67 Time <0.001
FB 1.25 ± 1.29 4.00 ± 2.86 3.17 ± 2.29 GxT 0.964
Mean 1.50 ± 1.79 4.13 ± 2.66 * 3.42 ± 2.45 *
Stomach Upset PLA 0.50 ± 1.00 1.17 ± 1.53 0.83 ± 1.64 Time 0.004
FB 0.50 ± 0.80 2.33 ± 2.81 0.50 ± 1.00 GxT 0.104
Mean 0.50 ± 0.88 1.75 ± 2.29 * 0.67 ± 1.34
Fasted Mid-Exercise Post-Exercise
Data are means ± standard deviations (SD) or standard error of the mean (SEM).  A multivariate 
analysis revealed overall Wilks' Lambda time (p<0.001) and treatment x time (p=0.269) effects.  
Greenhouse-Geisser univariate p-levels are presented for each variable. PLA=Placebo, FB=Food 
Bar, GxT represents group x time interaction.  * denotes p<0.05  difference from baseline.  
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Discussion and Conclusion 
We previously reported that ingesting a whey protein energy bar with IMO as the 
source of carbohydrate had a GI of 34 and a glycemic load of 8.5 [243]. Additionally, 
that ingesting this energy bar increased insulin to a greater degree while maintaining 
blood glucose to a better degree compared to a dextrose control [243]. Theoretically, 
ingestion of this food bar prior to, during, and/or following exercise could serve as a 
low-glycemic source of carbohydrate and lessen the catabolic effects of intense exercise. 
Table 16. Readiness to Perform Questionnaire
Variable Treatment Effect p-Level
PLA 3.58 ± 0.79 3.58 ± 0.79 3.83 ± 0.83 Time 0.591
FB 3.67 ± 0.49 3.67 ± 0.78 3.76 ± 1.15 GxT 0.591
Mean 3.63 ± 0.65 3.63 ± 0.77 3.75 ± 0.99
PLA 3.83 ± 1.11 3.58 ± 1.00 4.08 ± 1.00 Time 0.065
FB 3.92 ± 0.90 3.42 ± 1.24 3.83 ± 0.94 GxT 0.689
Mean 3.88 ± 0.99 3.50 ± 1.10 3.96 ± 0.95 ^ 
PLA 3.83 ± 0.83 4.00 ± 1.04 4.17 ± 0.94 Time 0.250
FB 4.08 ± 0.90 3.67 ± 1.30 4.00 ± 0.85 GxT 0.150
Mean 3.96 ± 0.86 3.83 ± 1.17 4.08 ± 0.88
PLA 3.08 ± 0.67 3.50 ± 0.67 3.75 ± 0.97 Time 0.004
FB 3.33 ± 1.07 3.17 ± 1.11 3.92 ± 1.00 GxT 0.237
Mean 3.21 ± 0.88 3.33 ± 0.92 3.83 ± 0.96 *^
PLA 3.83 ± 0.94 3.92 ± 0.79 4.08 ± 0.67 Time 0.035
FB 3.83 ± 1.03 3.33 ± 1.07 4.17 ± 0.94 GxT 0.159
Mean 3.83 ± 0.96 3.63 ± 0.97 4.13 ± 0.80 ^ 
PLA 4.08 ± 0.67 3.08 ± 1.00 3.08 ± 1.08 Time 0.007
FB 4.00 ± 0.43 3.50 ± 0.90 3.25 ± 1.36 GxT 0.655
Mean 4.04 ± 0.55 3.29 ± 0.95 † 3.17 ± 1.20 *
Optimistic about 
future 
performance   
I feel vigorous & 
energetic      
My appetite is 
great 
I have little 
muscle soreness 
Data are means ± standard deviations (SD) or standard error of the mean (SEM).  A multivariate analysis 
revealed overall Wilks' Lambda time (p=0.001), treatment x time (p=0.186) effects. Greenhouse-Geisser 
univariate p-levels are presented for each variable. PLA=Placebo, FB=Food Bar, GxT represents group x 




workout   
Fasted Post-Exercise 48-hr Post
I slept well last 
night 
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The purpose of this study was to examine the effects of ingesting a commercially 
available low-glycemic whey protein energy/food bar with IMO as the source of 
carbohydrate prior to, during, and following exercise affects exercise capacity and/or 
recovery from intense-exercise. We hypothesized that ingestion this whey protein food 
bar containing IMO would promote a low to moderate glycemic response with a similar 
insulin response during exercise, help athletes maintain exercise performance capacity 
during an intense training session, and hasten recovery. Based on results observed, we 
accept our hypotheses. The following assesses the impact of ingesting this energy/food 
bar prior to, during, and following intense exercise on primary and secondary outcomes. 
Primary Outcome – Glucose Homeostasis 
Results of this study found that the glycemic and insulinemic response of ingesting 
the food bar prior to, during, and following intense exercise was more favorable in 
maintaining euglycemia than ingesting equivalent amounts of reference carbohydrate 
(dextrose). In this regard, blood glucose levels never increased outside of normal values 
after FB ingestion compared to an increase of up to 58% with dextrose. Blood glucose 
levels were significantly higher than baseline prior to and following exercise in the PLA 
treatment. Additionally, pre-exercise blood glucose levels in the PLA treatment were 
significantly higher than FB blood glucose values. Interestingly, even though glucose 
levels were only modestly increased following FB ingestion, insulin concentration and 
the GIR were significantly higher than baseline values in both treatments and the GIR 
following exercise was significantly higher with FB ingestion compared to the dextrose 
placebo. These findings indicate that FB ingestion promoted a more favorable glucose 
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homeostasis and anti-catabolic hormonal environment. These results support our initial 
findings that ingestion of this FB promotes a mild increase in blood glucose while 
serving to increase insulin levels to a greater degree than dextrose [243]. It also provides 
rationale as to why consumption of this FB may lessen exercise-induced catabolism 
and/or promote recovery from intense exercise. 
 There are several possible reasons for these findings. First, amino acid ingestion 
has been reported to modestly increase insulin levels [233, 258, 259] and co-ingestion of 
protein or amino acids with carbohydrate has been reported to promote a greater effect 
on insulin [233-236, 258, 260, 261]. The FB studied contained 25 g of IMO with 20 g of 
whey protein. Thus, it is possible that co-ingestion of IMO and whey protein promoted a 
greater increase in insulin than the dextrose placebo. Second, the FB was high in fiber 
and only contained 4 g of digestible carbohydrate (sugar) which would have likely 
promoted a more gradual release of glucose into the blood thereby facilitating a more 
sustained increase in insulin. There is evidence that consuming whey protein with fiber 
affects the glycemic response of co-ingested carbohydrates [262-264]. So it is possible 
that co-ingesting whey protein with a high fiber carbohydrate may have augmented 
insulin response. Third, although IMO is a prebiotic, it is classified as a type of 
oligosaccharide that has been reported to stimulate growth of “friendly” bacteria which 
improve gut function through the promotion of activity of the probiotic gut flora [208, 
237-239]. Therefore, it could be possible that intestinal absorption of glucose was 
enhanced thereby serving to help maintain blood glucose levels to a greater degree while 
the increased availability of amino acids served to stimulate insulin levels. Additional 
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research should examine the potential mechanisms associated with these findings.   
Secondary Outcome – Exercise Performance & Recovery 
 Since we previously found that ingesting this FB promoted a modest and more 
sustained increase in blood glucose, we hypothesized that ingesting this FB prior to and 
during intense exercise may help athletes maintain performance over time. Results of 
this study provides some support for this hypothesis. In this regard, we observed that 
total lifting volume from Set 1 to Set 2 and Set 3 was maintained to a greater degree 
during the FB treatment while significantly decreasing below baseline values with PLA. 
While it’s understandable that athletes/experienced lifters may not be able to maintain 
70% of 1RM for each exercise during an intense workout due to fatigue, this finding 
suggests that ingestion of the FB helped maintain the quality of the resistance-exercise 
training session. We also found that agility performance was improved from Sprint 1 to 
Sprint 2 in the FB treatment while being unchanged in the PLA treatment and that the 
participants performed the first 40 yard sprint -0.15 sec faster with FB compared to PLA. 
While this latter finding was not statistically significant, it represents a meaningful 
performance difference from an applied standpoint.     
We also hypothesized that since the FB we previously investigated increased insulin to a 
greater degree than dextrose and insulin serves as an anticatabolic hormone, ingesting 
this FB around an intense exercise bout may lessen exercise-induced catabolism and/or 
perceptions of delayed onset of muscle soreness (DOMS) [77, 78, 82, 242]. Results of 
this study found evidence that ingesting this FB may lessen perceptions of muscle 
soreness but it had limited effects on markers of catabolism or inflammation. In this 
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regard, participants rated the pain response to a standard amount of pressure applied to 
several locations on the thigh to be significantly higher than baseline values after 
exercise (VM site) and after 48 h of recovery (DVL and MVL) with PLA treatment 
while ratings in the FB treatment were unchanged. Ratings at the VM site also tended to 
be lower in the FB treatment compared to PLA after exercise. Additionally, participants 
did not respond as positively to the statement “I have little muscle soreness”. These 
findings support prior reports that whey protein supplementation can affect recovery 
and/or perceptions of muscle soreness in response to intense training [265-267]. 
However, there was less evidence indicating that ingestion of this FB prior to, during, 
and following intense exercise lessened markers of catabolism. In this regard, we found 
no significant effects on markers of whole body catabolism, muscle enzyme efflux, 
anabolic and catabolic hormones, or inflammatory markers. These findings support 
results of other studies that reported limited to no effects of consuming whey protein 
prior to and/or during exercise on markers of catabolism or inflammation [268-270]. 
Additional research is necessary to explore the impact of consuming whey protein with 
different forms of carbohydrate on markers of recovery from intense exercise.   
Finally, analysis of subjective ratings of symptoms revealed that ingestion of PLA 
and FB prior to, during and following exercise were well tolerated and had minimal 
effects on ratings of hypoglycemia, dizziness, headache, fatigue, and stomach upset. 
These findings indicated that both nutritional interventions were well tolerated. 
Moreover, while the treatments differed in caloric content and sweetness which could 
influence perceptions about appetite, hunger [224]; ingestion of the FB was associated 
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with a greater increase in feeling of fullness with some evidence of less hunger and 
greater satisfaction from food ratings. Finally, we did not observe significant differences 
between treatments in questions related to readiness to perform. Collectively, these 
findings indicate that the food bar studied serve as a good low-glycemic food choice for 
active individuals to consume prior to, during, and/or following intense exercise training. 
Limitations 
Although this study employed a randomized, crossover experimental design and 
assess the effects of consuming these nutritional interventions around an intense training 
consistent with the type of training many athletes perform, there are some limitations to 
the study that should be noted. First, the dextrose placebo was matched in CHO g (25 g), 
and was a reference carbohydrate for determining the GI and GL of the food source. 
However, it was provided as a gel and the placebo was not matched for total calories. 
This could have influence some of the differences observed in performance and/or 
perception of soreness. Second, while the study was sufficiently powered and a number 
of outcome variables were statistically significant, we found borderline significant levels 
with moderate to large effect sizes suggesting that having a larger n-size may have 
revealed more significant findings. Third, given we were trying to assess a normal 
training bout of exercise, we limited venous blood assessment data points and therefore 
may have missed some of the effects of the nutritional interventions on blood markers. 
Finally, we chose to have participants record and try to replicate nutritional intake during 
each treatment. While there were no significant differences in dietary records and 
participants fasted and refrained from exercise training and NSAID use prior to reporting 
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to the lab, it is possible that differences in diet, hydration, and/or rest between treatments 
may have influence results. With that said, the major strengths of this study were the 
randomized and crossover experimental design and assessment of a typical intense 
training bout used in the strength and conditioning of athletes. Additionally, the practical 
assessment of whether having athletes ingest a energy/food bar prior to, during, and/or 
following exercise has any influence on exercise training performance and/or recovery. 
Conclusion 
 Results of this study demonstrated that ingestion of a whey protein with IMO as 
the source of carbohydrate prior to, during, and following intense resistance-exercise and 
sprint conditioning maintained blood glucose and increased insulin to a greater degree 
than consuming a carbohydrate matched dextrose placebo. Additionally, FB ingestion 
helped maintain resistance and sprint exercise performance. However, markers of 
catabolism and inflammation were not affected. Results indicate that this FB can serve 
as a good low glycemic food option for individuals to take prior to, during, and/or 
following intense exercise. Additional research should evaluate the potential benefits of 
using IMO as a carbohydrate source in functional foods as well as other potential 
health/exercise effects of increasing dietary availability of IMO, as well as in longer 





CHAPTER V  
SUMMARY OF CONCLUSIONS 
Discussion 
Ingestion of nutrients prior to exercise contributes to fuel availability which may 
reduce catabolism during exercise and promote recovery.  Favorable performance 
benefits to training have been reported with low GI carbohydrate and protein 
supplementation in close proximity to exercise bouts, in particular if less than adequate 
amounts of carbohydrate are consumed beforehand.   Athletes commonly consume 
glucose/electrolyte solutions (GES), gels, and energy bars prior ro, during, and/or 
following exercise in order to increase carbohydrate and protein availability, sustain 
performance, and enhance recovery.  Many commercially available GES, gels, and 
energy bars have moderate to high GI which increases the likelihood of hypoglycemia 
during exercise.  
We sought to determine whether using a high fiber (isomalto-oligosaccharide, 
IMO) in a whey protein energy/food bar would serve as an effective source of 
carbohydrate and protein for athletes.  Previous research has demonstrated that IMOs 
could present an advantage on blood glucose and insulin in healthy adults.  Isomalto-
oligosaccharides have also proven their enhancing effects on metabolism, bifidogenic 
flora, bowel functions, and the immune system. In this context, IMOs could theoretically 
serve as a low glycemic food option for individuals on a low glycemic diet and/or 
athletes. It was therefore theorized that the implementation of a low GI carbohydrate and 
protein food bar with IMO ingested prior to and during exercise might be an effective 
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nutrient strategy to positively affect glucose homeostasis as well as enhance performance 
and recovery. 
The purpose of this study was to determine if consuming a food/energy bar 
containing whey protein and IMO as the source of carbohydrate would serve as an 
effective pre-, mid-, or post-exercise nutritional source for trained athletes. This was 
accomplished by conducting two studies. The first study determined the GI and GL of 
consuming one and two servings of this FB. The second study examined the effects of 
ingesting this FB prior to, during, and following exercise on glucose and insulinemic 
responses, exercise performance and/recovery. 
In the Pharmacokinetic Study, we hypothesized that ingestion of a mixed 
ingredient FB with IMO would promote a moderate glycemic response and positively 
affect perceptions about appetite and satisfaction from food with no evidence of 
hypoglycemia. The results of this study supported the contention. The FB examined 
demonstrated a glycemic and insulinemic response with one and two servings of this FB 
which were much more favorable than ingesting equivalent amounts of reference 
carbohydrate.  The glycemic index (GI) and glycemic load (GL) of the studied FB had a 
low GI of 34 and GL of 8.5 while promoting a similar insulin response to a high GI 
carbohydrate (dextrose) [203].  Perhaps the most interesting find stemming from the 
Pharmacokinetic Study was the fact that there was a similar insulin response to the 
reference carbohydrate (25 g of dextrose), despite blood glucose values remaining in the 
normal reference value range. This maintained glucose homeostasis combined with and 
similar insulin response to a reference carbohydrate PLA led to a significantly higher 
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insulin to glucose ratio (GIR) for the FB in comparison to the carbohydrate. The 
maintenance of blood glucose while observing a similar or greater insulin response has 
some potential applications for individuals involved in exercise programs. It is also 
highly beneficial for a FB to maintain blood glucose while reducing perceptions related 
to appetite with no effect of hypoglycemia symptoms. In this regard, additional research 
needed to be performed to evaluate the FB surrounding exercise. 
The insulin and glucose responses found in the Pharmacokinetic Study led us to 
then examine the acute effects of ingesting this commercially available whey protein 
food bar with IMO on exercise capacity and recovery when taken prior, during, and after 
a single resistance-exercise and sprint-conditioning bout. The purpose of this study was 
to examine how this FB would affect exercise capacity and/or recovery from intense-
exercise. We hypothesized that ingestion of this whey protein FB containing IMO would 
promote a low to moderate glycemic response with a similar insulin response during 
exercise, help athletes maintain exercise performance capacity during an intense training 
session, and hasten recovery. Based on results observed, we accept our hypotheses.  
Results of this study found that the glycemic and insulinemic response of 
ingesting the FB prior to, during, and following intense exercise was more favorable in 
maintaining euglycemia than ingesting equivalent amounts of reference carbohydrate 
(dextrose). In this regard, blood glucose levels never increased outside of normal resting 
values after FB ingestion compared to an increase of up to 58% with dextrose. In 
agreement with the Pharmacokinetic study, the insulin response was again higher than 
the dextrose PLA despite no significant changes in blood glucose. This led to an 
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increased GIR following exercise for the FB compared to the PLA, suggesting a more 
favorable glucose homeostasis and anti-catabolic environment. This provides rationale 
as to why consumption of this FB may lessen exercise-induced catabolism and/or 
promote recovery from intense exercise. 
The food bar also provided evidence to support an enhanced ability to maintain 
exercise-workloads and promote recovery. In this regard, we observed that total lifting 
volume from Set 1 to Set 2 and Set 3 was maintained to a greater degree during the FB 
treatment while significantly decreasing below baseline values with PLA. We also found 
that agility performance was improved from Sprint 1 to Sprint 2 in the FB treatment 
while being unchanged in the PLA treatment and that the participants performed the first 
40 yard sprint -0.15 sec faster with FB compared to PLA. Results of this study also 
found evidence that ingesting this FB may lessen perceptions of muscle soreness but it 
had limited effects on markers of catabolism or inflammation. These findings support 
results of other studies that reported limited to no effects of consuming whey protein 
prior to and/or during exercise on markers of catabolism or inflammation. Finally, 
subjective ratings to hunger, appetite, and hypoglycemia were well tolerated by this food 
bar. Collectively, these findings indicate that the FB studied serve as a good low GI food 
choice for active individuals to consume prior to, during, and following intense exercise 
training. 
Future Research 
Future studies should examine the potential mechanisms involved with the 
glucose homeostasis and improved insulinemic responses observed in this study. 
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Additional research is also needed to examine how IMO and foods using IMO as a 
carbohydrate source influence signs and symptoms of satiety. Research should also 
evaluate the potential benefits of using IMO as a carbohydrate in functional foods as 
well as other potential health effects of increasing dietary availability of IMO. In regard 
to performance, future studies should repeat this study design to examine if results 
observed with this FB on performance and recovery are consistently reproduced. 
Additionally, the practical assessment of whether having athletes ingest an energy/food 
bar prior to, during, and/or following exercise has any influence on exercise training 
performance and/or recovery.  It would also be prudent to test this FB on different 
populations (e.g. females, obese, diabetic, etc.). Additional research should evaluate the 
potential benefits of using IMO as a carbohydrate source in functional foods as well as 
other potential health/exercise effects of increasing dietary availability of IMO, as well 
as in longer study protocols over weeks to months. Lastly, future research should also 
evaluate the long-term chronic effects of IMO ingestion with exercise tolerance and 
performance. 
Conclusion 
In conclusion, the current studies demonstrated that ingestion of a whey protein 
with IMO maintained blood glucose and increased insulin to a greater degree than 
consuming a carbohydrate matched dextrose placebo. Moreover, this FB ingested prior 
to, during, and following a single bout of high volume resistance-training and sprint 
conditioning appears to be an effective dietary food in maintaining performance and 
reducing perceived muscle soreness. However, markers of catabolism and inflammation 
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were not affected. Results indicate that this FB can serve as a good low glycemic food 
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